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It is well-understood that the cause of apical periodontitis is due to bacteria within 
the root canal system.
1
  Intracanal medication is an adjunct used in the treatment of 
endodontic infections. Published studies suggest more than one-third of root canals still 
have cultivable microorganisms present after the end of the first treatment visit.
2
   
The currently used most common intracanal medication, calcium hydroxide, is 
sub-optimal due to its potential toxicity
2,3
 lack of anti-bacterial efficacy
4,5
 as well as its 
required length of time to be effective.
6
  One of the drawbacks of using calcium 
hydroxide is the ability of dentin to buffer the pH of calcium hydroxide, thus decreasing 
its potential as an antimicrobial agent.
7
  Haapasalo and Orstavik found that calcium 
hydroxide did not eliminate E. faecalis.
8
  Safavi et al. found that even after relatively 
extended time periods calcium hydroxide was unable to disinfect dentin tubules.
5
  A 
recent investigation has suggested calcium hydroxide dressing between appointments did 
not show the expected effect in disinfecting the root canal system and treatment outcome, 
indicating the need to develop more efficient inter-appointment dressings.
9
  Siqueira 
showed that when calcium hydroxide was prepared as a mixture using saline it was 
inadequate in eliminating Enterococcus faecalis and Fusobacterium nucleatum.
10
  
Estrela et al. performed a systematic review to conclude that currently used 
intracanal medicaments have a limited effect on bacterial biofilm.
11
  Additionally, anti-
biotic resistance is an increasing concern as F. nucleatum has shown reduced 
susceptibility or resistance to vancomycin, neomycin, erythromycin, amoxicillin, 
ampicillin, phenoxymethylpenicillin and tetracycline.
12
  Regarding the need to develop a 
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better intracanal medication, propolis is being considered a potential medication due to its 
variety of favorable characteristics. 
As previously stated, propolis has shown antimicrobial efficacy in many studies 
when tested against a variety of microorganisms. Recently, several studies have used in-
vitro models to evaluate the anti-microbial efficacy of propolis against E. faecalis, a 
pathogen of secondary endodontic infections.
4,13,14
   Several of these in-vitro studies have 
been performed under endodontic-relevant conditions within extracted teeth or dentin 
discs and compared with the most commonly used intracanal medicaments, calcium 
hydroxide and triple antibiotic paste. Propolis has been shown to be superior to both 
calcium hydroxide and triple antibiotic paste under these relevant conditions. 
 
PURPOSE 
A variety of in-vitro methods have been used to evaluate the anti-microbial effect 
of propolis including the agar diffusion or dilution method,
14
 macrobroth dilution 
method,
15
 Petri dish bioassay,
16
 and the use of microtiter plates. The current study will 
use a combination of similar methods in order to investigate the antibacterial efficacy of 
propolis against biofilm of the primary endodontic pathogen F. nucleatum.   
This study will use microbiological methods to investigate the antibacterial 
efficacy of propolis against the primary endodontic pathogen F. nucleatum in three 
phases: total biofilm plus planktonic combination, individual planktonic, and individual 
biofilm formations. This is of interest because F. nucleatum is one of the most common 
pathogens in the root canal system of teeth with primary endodontic infections.
17,18
  Since 
endodontic biofilms may be more resistant to treatment with medicaments than 
4 
 
planktonic bacteria, the anti-bacterial potential of propolis as an intracanal medicament 
against primary endodontic infections and biofilm are of clinical interest. 
 
HYPOTHESES 
 
Hypothesis Ho 
Propolis will not be inhibitory against F. nucleatum at low concentrations that 
could be applicable for use as an intracanal medication in endodontic infections as judged 
by its MIC/MBC/MBIC.  
 
Hypothesis Ha 
 
Propolis will have inhibitory activity against F. nucleatum at low concentrations 
that could be applicable for use as an intracanal medication in endodontic infections as 
judged by its MIC/MBC/MBIC.  
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HISTORY OF ENDODONTICS  
Endodontic procedures have been recognized as being performed as far back as 
the first century A.D.  Archigenes, a Greek, was credited with performing trephination 
into a pulp cavity, likely to establish pain relief.
19
  Not so long ago, the empirical era 
existed prior to the practice of evidenced-based endodontics. Dental and endodontic 
treatments were described by people like Pierre Fauchard, “the founder of modern 
dentistry,” who wrote the 1728 book, The Surgeon Dentist. He described endodontic 
anatomy, pathology, and treatment, offering the option of treating abscessed teeth with 
pulp extirpation by needle and a lead foil obturation. By the end of the 18
th
 century, 
Frederich Hersch further described the pathosis and treatment of dental disease. He found  
that diseased teeth elicit pain on percussion (a clinical test still in use today).
20
   
Koecker, the author of Principles of Dental Surgery in 1826, explored the 
connection between a necrotic pulp and periapical inflammation. He advocated the pulp 
capping procedure described as a means of retaining teeth to avoid necrosis of the pulp 
and the spread of inflammation and suppuration to the surrounding tissues. 
The practice of using arsenic became common in the 1800s as a painless way to 
remove painful pulpitis.
20
  Arsenic was the generic name given to drugs containing 
arsenious trioxide and was introduced by Spooner in 1836.
19
  Many techniques at this 
time were aimed at performing pulpotomies. Alternative therapies such as boring a hole 
through the alveolar bone and root apex to drain suppuration or perforating the cervical 
part of a tooth to drain hemorrhage were attempts at early endodontic treatment.  
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 Improvements in endodontic therapy included the invention of the broach by 
Edwin Maynard; the development of gutta-percha by Edwin Truman in 1847; the rubber 
dam by S. C. Barnum in 1864, and the suggestion of electric current pulp testing by 
Magitot in 1867. As evidenced by Barnum, establishing a state of asepsis was considered 
a potential factor in achieving success. In 1867 Joseph Lister documented his experience 
with antiseptic during surgery using carbolic acid.  Around this time Leber and 
Rottenstein had proved the presence of Leptothrix buccalis and were describing that 
decay could lead to a gangrenous pulp.  Following Lister’s methods of antiseptic, in 1873 
Witzel began using phenol in an attempt to sterilize pulps, and around this time Keyes 
described the use of iodoform as a pulp and periapical dressing.
20
 
As the connections among microbial infection, asepsis, and treatment of pulpal 
and periapical disease were unfolding, Rogers published an article in Dental Cosmos 
suggesting that pathogenic organisms were the cause of pulpal disease and that 
destruction of these organisms was imperative to successful treatment. Tomes in 1879 
and Underwood in 1882 began the change from the dead tooth theory to the septic theory.  
Their works not only made connections between necrosis and sepsis as contributing 
factors to pulpal disease, but they fueled a 30-year initiative to eliminate bacteria using 
caustic germicides. In 1895 chloropercha was developed by Dr. Bowman as a chloroform 
and gutta percha obturation method.  Pulp stump fixation was practiced using the less 
caustic formalin method as a replacement from the arsenic method, and phenols and 
iodoform were still in use for disinfection. In 1894 John Wessler presented his method of 
pulp capping using oil of cloves which contained 80-percent to 90-percent zinc oxide and 
eugenol. Interestingly, zinc oxide and eugenol are still in use today as one of the most 
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common types of root canal sealer.
21
  In 1915 Dakin
22
 published a description of the use 
of 0.5-percent to 0.6-percent sodium hypochlorite to be used as a wound antiseptic. 
In addition to the clinical methods being developed during this time, adjunctive 
tools for diagnosis were invented and incorporated in the early 1900s, such as the 
radiograph.  William Roentgen is credited with the discovery of X-rays. Dr. Kells, a 
dentist who published many articles and developed many patented inventions related to 
radiographs, is credited as the first dentist to use radiographs to study root canals.  
Unfortunately, his extensive experimentation with X-rays is claimed to have caused his 
death by cancer in 1928.
21
  The first dental X-ray unit was available in 1913 and in 1919 
a conventional dental X-ray unit was commercially available.
23
  Thomas Alva Edison 
even had an attempt to contribute to endodontics.  In 1898 he attempted to use calcium 
tungstate to create a fluorescent dental mirror. By 1930 their use was discouraged due to 
excessive radiation potential. In 1900 Price coined the term “blind abscess” to describe a 
periapical radiolucent lesion with no clinically apparent drainage.
21
  What he was 
describing would be described today as apical periodontitis.  In 1908 Dr. Rhein 
developed a technique for measuring canal length and degree of obturation by taking a 
wire film.
24
 
The use of local anesthetics was scant for many years even after the development 
of cocaine as a local anesthetic. Although many dentists used cocaine for approximately 
20 years, its risk of toxicity made it less than desirable. In 1905 Einhorn developed 
procaine (novocaine), which lacked ideal efficiency in the office as it was complex to 
prepare for clinical use as an anesthetic requiring boiling and cooling prior to aspiration 
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into a syringe. H. S. Vaughn is credited as the first to use the local anesthetic infiltration 
technique for pulpal extirpation.
21
 
The endodontic profession encountered challenges when Frank Billings focused  
attention on the connection between oral sepsis and bacterial endocarditis in 1904.
21
  
William Hunter contributed to this theory of focal infection in his historical lecture, “The 
Role of Sepsis and Antisepsis in Medicine.”23  These men theorized that systemic 
diseases were the result of foci of infection located in necrotic teeth. Rosenow 
contributed experimental work to support these theories that teeth and tonsils were the 
foci of infection for a variety of systemic diseases.
25
  He was able to show that 
streptococci were present in a variety of organs and capable of traveling to distant sites in 
the body via the bloodstream.
23
  Thankfully, opponents to this theory eventually prevailed 
to show there was no scientific basis for these claims. Reimann and Havens presented 
their position and published a review of literature to show that the “causative relationship 
of infections about the teeth and tonsils to systemic disease is unproved and that removal 
of teeth and tonsils in an effort to influence the course of systemic diseases is unjustified 
in the majority of cases.”25  Additionally, through the efforts of men within the dental 
community such as Coolidge and Johnson, the principle of preserving the pulpless tooth 
survived.
23
  To further refute the focal infection theory, in 1937 Logan’s work explained 
that the mere presence of microorganisms within tissues did not imply infection; that 
bacteria are often present within normal healthy tissues with no pathological 
significance.
23
  Even today, the focal infection theory remains present among some 
clinicians although it continues to have no sound scientific evidential support. Regarding 
bacteremia, which is the closest thing to the modern focal infection theory, it is suggested 
10 
 
that only patients with the highest potential risk of complications from bacteremia, such 
as those at risk for infective endocarditis, immunosuppression, or those with an 
orthopedic prosthetic device be medicated with antibiotics before treatment.  Even in 
these scenarios, the risk is considered unproven.
26
 
Amidst the challenges of defeating the focal infection proponents, stricter 
attention was directed toward aseptic techniques, diagnosis, and culturing.  In 1931 the 
hollow tube effect was described to explain the need to eliminate any void areas from 
root canal obturations.  The belief was that any void could allow for apical percolation of 
tissue fluid and enzymatic breakdown within the canal to trigger a periapical 
inflammatory response. Soon after, silver points were developed as a means to obturate 
canals with a material that had the same size and taper as the instruments used for 
debridement.  In addition, a cement of neo-balsam was used as a sealer with them.
23
  
Around the First World War, chloramine-T, which had been used in treating wounds, was 
incorporated into endodontic treatment as an intracanal medicament. Antibiotic use 
became a component of endodontic therapy in 1941 and 1944 when Fred Adams began 
using antibiotics within canals initially using sulfanilamide and subsequently using 
penicillin. At this time, Grossman was developing intracanal techniques to use penicillin 
and developed a method of using absorbent points with impregnated with penicillin.  
Several years later after more antibiotics became available and were used in combinations 
within the canal, Auerbach emphasized that asepsis could not be achieve solely by use of 
antibiotics and that the use of antibiotics combined with mechanical debridement was 
necessary.
23
   
11 
 
In 1959 Sargenti and Richter introduced N2, controversial because it contains  
contains paraformaldehyde and other unfavorable compounds.
23
 Methods of pulpal 
treatment have varied throughout time. Coolidge explained that the purpose of obturation 
was to obliterate the canal space and to seal the apical foramen from ingress of tissue 
exudate.
27
  Unique ideas were expressed as Ostby in 1961 proposed the possibility of 
instrumenting past the apex to stimulate a pseudo-pulp utilizing the growth potential of 
the periapical tissue.
27
  In our current variety of techniques today, pulpal regeneration is a 
concept widely researched.   
While all the discoveries of endodontic therapy were occurring, organized 
dentistry was developing speciality recognition in the field of endodontics.  In 1943 the 
American Association of Endodontists was formed. Harry Johnston coined the term 
endodontia based on the greek terms “endon” (within) and “ho dontas” (a tooth).  
Additionally in 1956 the American Board of Endodontics was formed in Illinois.
23
  Later, 
in 1963 endodontics was recognized by the American Dental Association as a specialty.
19
 
 
FOUNDATION OF ENDODONTICS 
“The ultimate goal of endodontic treatment is either to prevent the development of 
apical periodontitis, or in cases where disease is present, to create adequate conditions for 
periradicular tissue healing.”28  In the most well-known study in the field of endodontics,  
Kakehashi, Stanley, and Fitzgerald
1
 in 1965 created surgical pulp exposures on 
gnotobiotic germ-free rats and conventional rats with normal microflora. They found that 
apical periodontitis developed in conventional rats but not in germ-free rats. From this 
information, they concluded bacteria is required to develop apical periodontitis. Through 
history this has been reconfirmed. Moller et al.
29
 in 1981 used monkeys to conclude that 
12 
 
reactions in the periapical tissues were induced by microorganisms that established 
themselves within the necrotic pulp from the mouth. Of the teeth that were aseptically 
necrotized, those that were then inoculated with bacteria developed periapical 
inflammation, whereas teeth that were necrotic but remained uninfected had no periapical 
inflammatory reaction. These studies provide the classic foundation of knowledge that 
apical periodontitis is caused by microorganisms within the canal. Current research has 
also shown other microorganisms such as archaea, fungi, and viruses to be associated 
with endodontic infections but evidence is equivocal as to their involvement.
30-33
 One 
study “confirmed that cytomegalovirus or Epstein-Barr virus active infections are 
detected in more than 90 percent of granulomas of symptomatic and large periapical 
lesions.”31   
Considering how to provide adequate endodontic therapy, Stewart
34
 described the 
critical components: chemomechanical treatment, debridement, microbial control, and 
adequate obturation.  He considered the chemomechanical preparation step to be most 
critical. An additional description of the goal of endodontic treatment is said to be total 
elimination of intracanal microbes.
35
 
 
ANATOMY  
Root canal anatomy has been shown to be extremely variable. Much discussion 
has been attributed to the complex interlacing network within the canal system, accessory 
canals and roots as well as the anatomy of the apical foramen. A classic study by 
Kuttler
36
  in 1955 described the variability of the apical foramen. He explained there is a 
distance between the minor and major foramen and a funnel shape between them that 
disallows a hermetic seal if the root canal were to be treated past the minor foramen to 
13 
 
the major foramen. This distance was found to be 0.5 mm and is part of the foundation of 
knowledge to advocate debridement and obturation of roots to 0.5-mm coronal to the 
apical terminus. Contrary to this, in 2011 Meder-Cowherd and Williamson et al.
37
  
studied palatal roots of maxillary molars and found that most (65%) of canals did not 
demonstrate an apical constriction and that the apical region was variable. In 2008 using 
mandibular premolars, Hassanien
38
 found the CDJ and apical constriction are not the 
same point; the apical constriction was always found coronal to the CDJ. It was also 
found that the Root ZX (J Morita Co, Tokyo, Japan) brings the file tip closer to the CDJ. 
Green
39
 in 1960 found that approximately 50 percent of the major foramina terminate at a 
position up to 2 mm eccentric to the apex of the root.  
The anatomy of the mesiobuccal root of maxillary molar teeth has been 
extensively studied as the appearance of two canals has been determined to be very 
common.
40,41
  Gilles and Reader
42
 found a second mesiobuccal canal (MB2) in 90 percent 
of maxillary first molars and 70 percent of maxillary second molars. Verma and Love
43
   
agreed with this confirming the presence of a second MB canal in 90 percent of maxillary 
first molars using micro CT. Additionally, de Pablo
44
 described the mandibular first 
molar having complex anatomy with variable canal configurations and variable number 
of roots.  
Weine et al. 
40
 described three canal configurations in their study of maxillary 
molars:  
Type 1:  A single canal from pulp to apex. 
Type 2: Two canals that merge before the apex.  
Type 3: Two separate canals with two distinct apical foramina.  
14 
 
Type 4: Splits from one main canal to two separate canals with two distinct 
orifices was later described and is referenced in many studies.
44
 
Vertucci et al.
45
 described canal morphology in a more extensive manner. They 
provided a breakdown of eight canal configurations:  
Type 1: A single canal from pulp to apex.  
Type 2: Two separate canals that join and exit as one. 
Type 3: One canal that splits into two and rejoins as one prior to exiting its 
foramen. 
Type 4: Two separate canals with two distinct apical foramina. 
Type 5: One canal that splits into two separate canals with two distinct orifices. 
Type 6: Two separate canals that join within the root and then split to exit as two 
distinct orifices. 
Type 7: One canal starts, splits to two, rejoins as one, and splits to exit as two 
distinct orifices. 
Type 8: Three separate canals that stay separate. 
 
CHEMOMECHANICAL DEBRIDEMENT 
In 1968 Dudley Glick
27
 described the microbiological aspects of 
chemomechanical debridement. It was accepted that mechanical debridement or 
intracanal medication alone were insufficient by themselves to render a canal sterile.  
There was emphasis on using both mechanical and chemical disinfection to achieve 
asepsis within the canal. Much like today’s attempts to disinfect teeth with triple 
antibiotic paste, there was a variety of drug combinations to place within the canal, and 
each type of drug had its own limitations.   
15 
 
While many methods of chemomechanical debridement have been evaluated over 
time, few chemicals are consistently in use for the chemical disinfection of the root canal 
system. To list a few of the commonly investigated irrigation solutions: sterile water, 
saline, sodium hypochlorite (in a variety of concentrations), chlorhexidine (in a variety of 
concentrations), iodine potassium iodide, camphorated parachlorophenol, formocresol 
(formaldehyde and cresol) and hydrogen peroxide. In 1975 Spangberg et al.
46
 showed 
that 0.5-percent sodium hypochlorite was antibacterial, had the ability to dissolve 
necrotic tissue, and had a decreased toxicity due to dilution, yet it was unable to kill 
Staphylococcus aureus (whereas 1.0-percent sodium hypochlorite was able to do so).  
They claimed that in vital cases, the objective of irrigation solutions in cleaning the canal 
was aimed at removal of pulp and dentin, and the antimicrobial effect was a secondary 
goal. This was based on their understanding that in vital pulp cases, bacteria are not 
usually present in the canal. A study by Bystrom and Sundqvist
47
 in 1981 provided 
evidence that through mechanical debridement with saline, they were able to decrease the 
bacterial count within canals 100-fold to 1000-fold, and in some cases higher. Although 
this supports mechanical debridement of the canal, they concluded that the supportive 
action of antimicrobial solutions would be necessary for further elimination of the 
bacteria that remain. They followed this research with further experimentation in 1983 
that concluded the use of 0.5-percent sodium hypochlorite is more effective than saline as 
a root canal irrigant. They showed that more canals with no bacterial growth were found 
in the teeth treated with sodium hypochlorite.
48
  Harrison and Hand
49
  in 1981 showed 
that 5.25-percent sodium hypochlorite was the most effective antimicrobial solution when 
compared with saline, 0.5-percent sodium hypochlorite, and a mixture of 3.0-percent 
16 
 
hydrogen peroxide mixed with 5.25-percent sodium hypochlorite. They additionally 
concluded that dilution of sodium hypochlorite from 5.25-percent to 0.5-percent 
decreased its antimicrobial efficacy.  In 2008 Mohammadi
50
 conducted a review of the 
literature on sodium hypochlorite and explained several of its properties. It is a good 
choice for endodontic use against bacteria, biofilm, and fungi and has tissue-dissolving 
properties. Additionally, the authors described the in-vitro ability to enhance the 
bactericidal efficacy by heating NaOCl; the toxicity and complications with clinical use 
of sodium hypochlorite; the examination of sodium hypochlorite accidents with extrusion 
beyond the apex, or accidental introduction into the eye. Current literature supports using 
higher concentrations as well as longer exposure times for the greatest effect when using 
sodium hypochlorite.  Retamozo et al. 
51
 found the most effective concentration and 
length of time to eliminate E. faecalis was 5.25-percent sodium hypochlorite at 40 
minutes.  
One of the additional properties of sodium hypochlorite of significant benefit is its 
ability to dissolve necrotic tissue.  In 1978 Hand et al. 
52
 confirmed the effectiveness of 
5.25-percent sodium hypochlorite as a necrotic tissue solvent and simultaneously 
confirmed the ineffectiveness of saline, distilled water, and 3.0-percent hydrogen 
peroxide, 1.0-percent sodium hypochlorite, and 0.5-percent sodium hypochlorite. Current 
literature confirms the ability of 2.5-percent sodium hypochlorite to completely dissolve 
pulp tissue, and the ability of 17-percent ethylenediaminetetraacetic acid (EDTA) to have 
minimal pulp tissue dissolvent action.
53
 
Generally accepted as the most effective chelating agent, “EDTA has prominent 
lubricant properties and is widely used in endodontic therapy. It is used to enlarge root 
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canals, remove the smear layer, and prepare the dentinal walls for better adhesion of 
filling materials.”54 Baumgartner and Mader55 described the ability of alternating sodium 
hypochlorite and EDTA for maximal tissue dissolution. Sodium hypochlorite dissolves 
the organic component of the pulp, and EDTA is able to dissolve the inorganic 
component. Calt and Serper
54
 advised using EDTA no longer than one minute for smear 
layer removal due to its ability at longer time frames to excessively erode intertubular and 
peritubular detin.  
In recent decades, the reputation of chlorhexidine (CHX) has risen as a potential 
intracanal irrigation solution. Ohara et al.
56
 found that 0.2-percent CHX displayed the 
most effective antibacterial activity when compared with 5.25-percent NaOCl, 3.0-
percent hydrogen peroxide, and 17-percent EDTA tested under laboratory conditions 
against six common endodontic pathogens (Peptococcus magnus, Propionibacterium 
acnes, Veillonella parvula, Lactobacillus fermentum, Porphyromonas (Bacteroides) 
gingivalis, F. nucleatum. Other studies have shown limited benefit from using CHX 
rather than NaOCl as the primary intracanal medicament of choice.   
Several other relatively new medicaments have come onto the market as potential 
irrigation solutions such as BioPure MTAD (Dentsply Tulsa). MTAD consists of a 
mixture of doxycycline, citric acid, and a detergent (Tween 80).
57
 Several studies show a 
lack of beneficial results in comparison with NaOCl for improvement in intracanal 
disinfection. A review of the literature regarding MTAD stated the initial studies show 
good antimicrobial activity against E. faecalis, but later studies that simulated clinical 
conditions showed a lesser antimicrobial effect of MTAD.
57,58
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Many studies have shown medicaments cannot completely eradicate bacteria from 
the root canal system.
59
  Although we may not be able to completely eliminate all 
bacteria from the root canal system, irrigation solutions such as NaOCl and chlorhexidine 
appear to decrease bacterial counts favorably to encourage healing.
60
  Debridement with 
proper irrigation solutions and techniques are an important part of the one-versus-two 
appointments debate.  In 2012 Siqueira
61
 found that in using 5.0-percent NaOCl, they did 
not completely eliminate bacteria from the teeth treated in one visit, and that only two 
cases were bacteria-free in the two-appointment group. This finding exemplified the 
complexity of the root canal system and the inability to completely eradicate bacteria 
from teeth. 
An informed use of these medicaments is essential because current literature has 
shown potential interactions among irrigation solutions. Basrani et al.
62
 using mass 
spectrometry presented the interaction between sodium hypochlorite and chlorhexidine, 
which produces a precipitate considered to be para-chloroaniline (PCA). PCA is known 
to be cytotoxic through formation of methemoglobin and was shown to have carcinogenic 
potential in animal studies. Further investigation has shown the chemical composition of 
the products may appear to be different depending on the methodology of chemical 
evaluation. Nowicki and Sem
63
 used nuclear magnetic resonance (NMR) spectroscopy to 
determine that the chemical composition of the precipitate contains fragments of 
chlorhexidine, which are chlorophenylguanidyl-1,6-diguanidyl-hexane (PCGH) and 
parachlorophenylurea (PCU) and not PCA. Additionally, a study by Thomas and Sem 
using a NMR analysis found no measurable quantity of PCA.
64
  Several studies have 
suggested an intermediate rinse in between the use of NaOCl and chlorhexidine to 
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prevent the formation of PCA. Krishnamurthy et al.
65
 found that absolute alcohol 
eliminates all formation of the apparent precipitate between NaOCl and chlorhexidine 
and that saline or sterile water will decrease precipitate formation, but not eliminate it. A 
study by Mortenson et al.
66
 comparing citric acid, EDTA, and saline showed that these 
three medicaments decrease, but do not eliminate the formation of PCA.  From these 
studies, it appears most prudent to use absolute alcohol as an intermediate rinse in cases 
utilizing NaOCl and CHX.  Given EDTA is often used prior to the CHX rinse, it may be 
most logical to use the EDTA, followed by alcohol to enable two intermediate flushes 
between the NaOCl and the CHX. 
 
OBTURATION  
In 1967 Schilder
67
 described the ultimate goal of root canal therapy is “to 
eliminate the root system as a source of infection and inflammation to the apical 
periodontium after irreversible pulp pathosis.” He described that the final product should 
be an obturation of the canal system in three dimensions.
68
  In 1940 Grossman described 
the criteria for an ideal endodontic filling material: 
1. Easily introduced. 
2. Liquid or semisolid and becomes solid. 
3. Seals both apically and laterally. 
4. Does not shrink. 
5. Impervious to moisture. 
6. Bacteriostatic. 
7. Non-staining. 
8. Non-threatening to periapical tissues. 
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9. Easily removed. 
10. Sterile or sterilizable. 
11. Radiopaque. 
He additionally described the need to properly clean and shape the canal system 
in order to achieve a successful obturation.
69
 
Historically, various methods have been used to attempt to obturate the canal.  
Silver points were once a common practice, but due to their inability to create an 
adequate seal as well as their tendency to corrode, they are no longer advisable.
70
  
Sargenti paste, or “N2” was a mixture of antibiotics, hydrocortisone, paraformaldehyde, 
and zinc-oxide-eugenol cement.
71
  Its use is no longer recommended due to its high 
potential for cytotoxicity and inflammatory reactions. Newton, Patterson, and Kafrawy
72
 
found that monkey teeth with pulpitis treated with this technique developed reactions of 
apical periodontitis and osteomyelitis at six- and 12-month follow-up histologic 
examinations.  
Another more recent obturation material on the market is Resilon. Resilon is 
promoted as a resin-based obturation material used with a resin-based sealer that 
supposedly creates a monoblock seal.  Although this sounds favorable, untoward 
properties of this material have been researched, such as polymerization shrinkage; when 
the material sets and shrinks it leaves gaps between the obturation material and dentin 
where microorganisms could inhabit.
73
  Additional criticisms of this material have been 
made due to its susceptibility to alkaline hydrolysis and enzymatic hydrolysis.
74,75
  The 
polycaprolactone component of Resilon has been described as being biodegradable by 
bacterial and salivary enzymes such as cholesterol esterase and lipase PS.
75,76
  Clinicians 
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have described finding root canals obturated with Resilon to develop apical periodontitis 
in cases that previously had no apical periodontitis.
77
 
The most commonly used obturation material is gutta-percha. Friedman et al.
78
 
described that gutta-percha is composed of 20- percent gutta-percha (rubber), 66-percent 
zinc oxide (filler), 11-percent barium sulfate (radiopacifier), and 3-percent wax 
(stabilizer).  Schilder
79
 described the phase transitions that occur with heating gutta-
percha.  Gutta-percha exists in the beta-semicrystalline phase until it undergoes a phase 
transition to the alpha phase upon heating. Senia et al.
80
 described the property to rapidly 
sterilize gutta-percha cones prior to their use with a 1-minute application of 5.25-percent 
sodium hypochlorite. Gutta-percha cones have been shown not to cross-react 
immunologically with natural rubber latex; thus, gutta-percha can be presumed to be safe 
for use in patients even if they have a latex allergy.
81,82
 
Warm vertical condensation, cold lateral condensation, warm lateral 
condensation, and warm thermoplasticized gutta-percha are commonly practiced methods 
of gutta-percha obturation. A meta-analysis by Peng
83
 et al. found that warm gutta-percha 
obturation methods were more likely to demonstrate overextensions of obturation 
materials than the cold lateral technique. Otherwise, they found post-operative pain, long-
term outcomes, and obturation quality were similar between warm and cold gutta-percha 
methods. Reader et al.
84
 compared warm techniques to cold lateral and found more lateral 
canals obturated with gutta-percha in the warm techniques. Whatever method is used, 
Schaeffer, White, and Walton
85
 conducted a meta-analysis indicating that a better success 
rate is achieved when obturation is completed at or short of the apex in comparison with 
past the apex.  
22 
 
INTER-APPOINTMENT MEDICATION  
In addition to medicaments used during the appointment, inter-appointment 
medication has been suggested to promote success of root canal therapy. One of the 
primary goals of inter-appointment medication is to increase the ability to eradicate 
bacteria from the canal. Hermann introduced the use of calcium hydroxide as an 
antibacterial dressing in 1920. In 1985 Bystrom, Claesson, and Sundqvist
86
 compared the 
effects of calcium hydroxide, camphorated paramonochlorophenol, and camphorated 
phenol as inter-appointment medicaments. They found better antimicrobial success with 
calcium hydroxide and suggested its use for intracanal medication. Intracanal medication 
is an adjunct used in the treatment of endodontic infections as studies suggest more than 
one-third of root canals still have cultivable microorganisms present after the end of the 
first treatment visit.
2
   
An extensive review of the properties of calcium hydroxide was done by Farhad 
and Mohammadi
7
 in 2005 describing its variety of properties and applications including 
its use as an inter-appointment medicament. They describe that when the calcium and 
hydroxyl ions dissociate, there is a high pH environment created by the hydroxyl ions.  
Bacteria are unable to grow or survive at this high pH.  There are several mechanisms by 
which these hydroxyl ions are antibacterial. The bacterial cytoplasmic membrane is 
disrupted by the peroxidation reactions occurring between hydroxyl ions and lipids 
within the phospholipid membrane. Additionally, cellular protein denaturation occurs 
because enzymatic activity is disrupted by the high pH.  Bacterial DNA is disrupted by 
the hydroxyl ions and potentially even fatal mutations occur by the free radicals formed.  
Clinically, Nerwich et al.
35
 showed that with intracanal dressing of calcium hydroxide, 
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the pH of outer root dentin began to rise between 1 day to 7 days and peaked at 2 weeks 
to 3 weeks.  These findings support that hydroxyl ions diffuse through dentin during 
calcium hydroxide dressing, although other authors like Fuss et. al.
87
 questioned the 
ability of a pH change at the outer root dentin. They showed that at seven days there was 
not a noticeable pH change in a medium surrounding the outer root surface when 
examining intra-canal calcium hydroxide in vitro.   
Several authors have evaluated the optimal time to leave calcium hydroxide 
within the canal as an inter-appointment medication. Sjogren and Sundqvist
6
 supported a 
seven day medication to eliminate bacteria. Shuping
88
 exemplified efficient antibacterial 
effect at seven days. The study by Nerwich and Messer would suggest a 2-week to 3- 
week application could have optimal benefit.
35
  Andreasen suggested using calcium 
hydroxide up to 1 month to avoid weakening root dentin.
89
 
One of the properties of calcium hydroxide that appears to be unique is its ability 
to detoxify endotoxins such as lipopolysaccharide (LPS).  Sodium hypochlorite and 
chlorhexidine have not shown the ability to detoxify LPS, making this a unique property 
in the additional use of calcium hydroxide in endodontic treatment.
90
  Safavi and 
Nichols
91
 concluded that calcium hydroxide hydrolyzed the lipid moiety of bacterial LPS, 
resulting in the release of free hydroxy fatty acids, thus having the potential clinical 
benefit of detoxifying LPS.  
Antibiotics as intracanal medications have been used as individual and 
combination formulations. Triple antibiotic paste (TAP) is a common term used to 
describe a mixture of ciprofloxacin, minocycline, and metronidazole. Hoshino, Sato and 
colleagues
90,91
 have shown this combination has excellent efficacy as a potential 
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intracanal medication to penetrate dentin and kill bacteria. The use of TAP has been 
reported clinically and is often considered in cases with trauma to immature permanent 
teeth.
92
  Banchs and Trope
93
 have described the use of TAP as part of their 2004 potential 
treatment protocol in the revascularization of immature permanent teeth.  Furthermore, 
double antibiotic paste containing ciprofloxacin and metronidazole shows clinical 
efficacy and has been suggested to avoid the discoloration that minocycline may cause.
94-
96
 
A recent in-vivo clinical study presents an alternative to using calcium hydroxide 
as an inter-appointment dressing. The authors examined the use of “limewater” slurry, 
which is calcium hydroxide slurry, as an incorporated rinse during single-visit 
disinfection.  They found the calcium hydroxide slurry decreased endotoxin by 99.18 
percent, whereas use of intracanal medication of calcium hydroxide for 14 days without a 
final rinse of limewater or polymyxin B decreased endotoxin by 99.2 percent.
97
  These 
results may have clinical implications for the use of limewater slurry to be used near the 
end of an appointment prior to a final rinse rather than an inter-appointment medication. 
In 2012 Vera, Siqueira, Ricucci and colleagues
61
 found their “2-visit protocol by 
using an inter-appointment medication with calcium hydroxide resulted in improved 
microbiological status of the root canal system when compared with the 1-visit protocol.”  
They concluded that the use of inter-appointment medication is necessary to maximize 
bacterial reduction. Similarly, Shuping et al.
88
 found that with instrumentation using 
sodium hypochlorite, 61.9 percent of canals were rendered bacteria-free and placement of 
calcium hydroxide for at least one week rendered 92.5 percent of the canals bacteria-free.  
They suggested using calcium hydroxide to more predictably eliminate bacteria. 
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Additionally, Siqueira
98
 in 2012 found that although there are ways to optimize single 
visit disinfection, there is a lack of consistent clinical evidence to predictably reduce 
microbes without the use of an inter-appointment medication.   
 
PROPOLIS 
Propolis is a resinous substance that honeybees produce and use for protective 
effects to seal their hives. It has been used for a variety of purposes in folk medicine for 
centuries. The chemical composition of propolis is very complex and includes organic 
compounds such as phenolic compounds, esters and many different known flavonoids 
and flavonones, such as pinocembrin, pinostropin, isalpinin, pinobanksin, quercetin, 
naringenin, galangine, and chrysin. 
As a potential intracanal medicament, Propolis is antimicrobial,
16,99-104
 anti-
inflammatory,
105
 anti-osteoclastic,
106
 anti-quorum sensing,
107
 anti-biofilm,
103
 and 
immunomodulatory. The antibacterial activity has been linked mainly to the flavonoid 
content and to the phenolic compounds, terpenes, and aromatic acids and esters that have 
been found in propolis.
108
 Although both propolis and honey are produced by bees, 
propolis is different from honey and has a higher antimicrobial effect.
99
 The chemical 
composition of propolis is also highly variable and depends on the local flora at the site 
of collection.   
Propolis has been shown to have antimicrobial effects against various microbes 
such as Bacillus subtilis, S. aureus, methicillin-resistant S. aureus, Staphylococcus 
epidermidis, Enterobacter aerogenes, Streptococcus pyogenes, Streptococcus mutans, 
Streptococcus sobrinus, Micrococcus luteus, Enterococcus faecalis, Escherichia coli, 
Pseudomonas aeruginosa, C. albicans, Candida tropicalis, Salmonella typhimurium, 
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Prevotella nigrescens, F. nucleatum, Actinomyces israelii, and Clostridium 
perfringens.
14,16,99-103,109-111
  Several commercial formulations of propolis were examined 
and it was concluded that flavonoid content above 1.0 percent has antimicrobial 
activity.
101
  Propolis from different sources was also shown to have differing 
antimicrobial effects and is often described as ethanol extract of propolis (EEP). Propolis 
from Turkey, Iran, Tunisia, Brazil, Poland and others were shown to have antimicrobial 
properties.
16,99,100,109,112
 
As described, many in-vitro studies have shown propolis to be an effective anti-
microbial medication against bacteria of endodontic origin.
4,13,15,108,113
  Additional 
appealing properties of propolis as a potential intracanal medication are its ability to 
promote healing, to reduce cytotoxicity compared with current medicaments, to inhibit 
osteoclastogenesis as well as osteoclast maturation and osteoclast activity, to affect 
inflammatory cytokine expression, and to reduce apoptosis and to enhance periodontal 
ligament cell metabolic activity and proliferation.
106,114-120
  It also has been shown to have 
a faster anti-bacterial effect
4
 and has shown physical properties that would make it 
suitable for placing as an inter-appointment dressing.
121
   
Neiva et al. found that propolis reduced LPS-induced inflammatory cytokines 
from pulp cells and osteoclasts.
114
  Harris described the property of propolis to block 
osteoclastogenesis and osteoclast activity downstream of COX activity.
106
  Pileggi 
published a study finding that propolis inhibited osteoclast maturity and fusion of 
osteoclast precursors.
120
  These properties are intriguing as having implications toward a 
potential role in the prevention and healing of resorption and apical periodontitis.  
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Clinicians are aware of the potential of propolis and clinical studies and case 
reports are published stressing its potential induction of healing and anti-bacterial 
effects.
115,122
  A case report regarding the retreatment of two previously non-surgically 
and surgically treated teeth involved the same type of propolis that will be used in our 
experimental model. They used 100-percent propolis powder mixed with propylene 
glycol.
122
  Since 2011, there have been over 280 research publications with the word 
“propolis” in their title. 
 
F. NUCLEATUM 
F. nucleatum is in the genus Fusobacterium, which belongs to the family 
Bacteroidaceae. The name Fusobacterium originates from fusus, meaning a spindle, and 
bacterion, meaning a small rod; hence it is a small, spindle-shaped rod.  Additionally, the 
term nucleatum stems from the nucleated appearance often seen in light and electron 
microscope preparations due to the presence of intracellular granules. F. nucleatum is 
non-spore-forming, non-motile, and gram-negative. Although it is considered an 
anaerobe, it may grow in the presence of up to 6.0-percent oxygen.
12
  LPS found on F. 
nucleatum is typical of gram-negative bacteria with its typical lipid A component and O-
antigen polysaccharide.  Clinically, “F. nucleatum is one of the most common oral 
species isolated from extra-oral infections, including blood, brain, chest, lung, liver, joint, 
abdominal, obstetrical and gynecological infections and abscesses.”123  It has also been 
associated with pregnancy complications and pre-term, low- birth-weight babies.
123
   
 One of the most discussed aspects of F. nucleatum is its ability to have an 
additive or synergistic effect with other bacterial species in co-infections.  F. nucleatum 
possesses outer membrane proteins that are of interest in regards to coaggregation, 
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antimicrobial susceptibility, and cell nutrition. FomA is considered the major outer 
membrane protein of F. nucleatum.
124
  It has been speculated that FomA, an outer 
membrane protein in the form of a porin may contribute to the antimicrobial 
susceptibility of F. nucleatum.
12
  FomA has been suggested to participate in the 
coaggregation process. It has been shown that FomA forms trimeric, water-filled 
channels in lipid bilayer membranes, acting as non-specifc pores.
124
  Research has shown 
neutralization of FomA considerably eliminated the enhancement of co-aggregation, 
biofilms, and production of volatile sulfur compounds mediated by an inter-species 
interaction of F. nucleatum with Porphyromonas gingivalis.
125
 
F. nucleatum also contains adhesins. These outer membrane proteins are utilized 
in adhesion and co-aggregation to create multi-species biofilms. One of the adhesin 
proteins on F. nucleatum is called RadD.  RadD has been shown to be a critical 
component in inter-species adherence and biofilm architecture.
126
  Additionally, the 
adhesive properties of F. nucleatum are not restricted to bacteria. This microbe is able to 
attach to epithelial cells, erythrocytes, and immune cells. Hemagglutinins, which are 
adhesins on F. nucleatum, are utilized in hemagglutination and have shown to adhere to a 
variety of cells and collagen.
12
 
Outer membrane proteins of F. nucleatum are involved in more than co-
aggregation and biofilm formation. Fap2 and RadD are outer membrane proteins that 
have been shown to induce human lymphocyte cell death. This is a unique property 
because a majority of mechanisms of cell death induction are based on protein and toxin 
transfer from bacteria to host cells.
127
  F. nucleatum also has the ability to secrete serine 
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proteases, which degrade extracellular matrix proteins such as fibronectin and fibrinogen 
in addition to their ability to degrade collagen type I and IV.
123
 
F. nucleatum has been shown to be one of the most common microbes found in 
primary endodontic infections. Rocas et al. found F. nucleatum to be one of the most 
prevalent species found in asymptomatic primary endodontic infections using reverse-
capture checkerboard DNA-DNA hybridization.
128
  Siqueira et al. found F. nucleatum to 
be the most frequently detected species in symptomatic primary endodontic infections of 
acute apical abscesses using reverse-capture checkerboard DNA-DNA hybridization.
129
  
Using a culture technique Gomes et al. found F. nucleatum to be one of the most 
prevalent types of bacteria involved in primary endodontic infections.
130
  Molecular 
methods have enhanced the ability to detect specific microorganisms and to provide a 
quantitative analysis of the different species.  Using checkerboard DNA-DNA 
hybridization, Sassone et al. found F. nucleatum to be one of the most common microbes 
found in primary endodontic infections in both unexposed and exposed canals.
131
  
Siqueira and colleagues found F. nucleatum to be prevalent in the apical third of canal 
spaces in 6 of 23 teeth (26%) using a nested polymerase chain reaction assay
132
 and as 
one of the most prevalent species in the apical root canal as detected by reverse capture 
checkerboard DNA-DNA hybridization.
17
  Baumgartner et al. found variability in the 
presence of F. nucleatum based on geographical region. F. nucleatum was much more 
prevalent in acute apical abscesses in the US when compared with Brazil.
133
  Therefore, 
the prevalence of F. nucleatum in primary endodontic infections in the US is well 
established. 
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BIOFILM  
“Biofilm can be defined as a sessile multi-cellular microbial community 
characterized by cells that are firmly attached to a surface and enmeshed in a self-
produced matrix of extracellular polysmeric substance (EPS), usually polysaccharide.”134  
Another author describes biofilms as “matrix-enclosed microbial aggregations that adhere 
to biological or non-biological surfaces.”135  This description has been seen in additional 
articles.
136
  Biofilms represent specific bacterial communities that may have a 
polymicrobial makeup. The ability to form biofilms is regarded as a virulence 
factor.
134,136
  Biofilms have specific structural, physical, chemical, and biologic features.  
They are not randomized assortments of bacteria; rather, they are an aggregation of 
bacteria that interact and position themselves for specific reasons. One of the features of 
biofilms that are advantageous to bacterial survival is their ability to afford protection to 
certain bacteria within the biofilm from host defenses, other competing microorganisms, 
environmental factors and antimicrobial agents.
134
  This feature has great relevance to our 
study of testing an antimicrobial agent against F. nucleatum biofilm.   
“Biofilms are controlled by a process called quorum-sensing triggered by species-
specific, small, diffusible auto-inducers and small peptides.”137 Quorum-sensing is how 
microorganisms communicate within biofilm and maintain their homeostasis, structure 
and function.  It is interesting to mention that “several herbal, animal and microbial 
extracts possess quorum-quenching activity.”137  This is of interest because inhibition of 
quorum-sensing could be a way that propolis acts in a biofilm-inhibitory manner. 
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MATERIALS AND METHODS 
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BACTERIAL STRAINS, MEDIA, AND PROPOLIS 
A loop containing colonies of F. nucleatum (ATCC 10953) from a 24-h to 48-h 
blood agar plate (see Figure 4) was picked and passed into 5 ml of Brain Heart Infusion 
broth (Difco, Detroit, MI) containing 5 g of Yeast Extract/L supplemented with 5.0-
percent (v/v) hemin/vitamin K solution (BHI-YE; Difco) (see Figure 5) and incubated 
anaerobically for 24 hours at 37 ºC in a GasPak jar (see Figure 6).
138
  The propolis 
(Ecuadorian Rainforest LLC, Belleville, NJ) used is a previously studied
115,139
 
commercial formulation powder (see Figure 1) that was dissolved in dimethyl sulfoxide 
(DMSO) to create a stock solution of 50,000 ug/ml propolis. DMSO was the chosen 
solvent.
140,141
   The positive control contained BHI-YE (with 5.0-percent v/v 
hemin/vitamin K) inoculated with F. nucleatum. There will be a negative control for each 
test concentration. One negative control group containing BHI-YE (with 5.0-percent v/v 
hemin/vitamin K) with no addition of F. nucleatum will be used.  Additional individual 
negative controls followed the same concentration of propolis in DMSO: BHI-YE (with 
5.0-percent v/v hemin/vitamin K) as compared with their test group with the exception of 
having no addition of F. nucleatum. An additional control plate with quadruplicate well 
evaluation will contain dilutions of DMSO to verify its lack of antimicrobial efficacy at 
the concentrations being used.  
The dilution of propolis dissolved in DMSO that shows good solubility will be 
tested as a whole, although microscopic fragments of propolis may appear to be 
insoluble. The extent of whether the active antibacterial components of propolis are 
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soluble or insoluble is not being tested. The propolis in toto will be used, because the aim 
of this study is not to determine precise components of propolis that are antibacterial, or 
whether they are retained in the soluble or microscopically insoluble portions. Previous 
studies have shown a variety of antibacterial components of propolis, and the focus of 
this study is to determine the antibacterial efficacy of a specific commercially available 
propolis powder. 
 
MINIMUM INHIBITORY CONCENTRATION (MIC) 
AND MINIMUM BACTERICIDAL CONCENTRATION (MBC) 
 
MIC is the lowest concentration of propolis that is required to inhibit growth of F. 
nucleatum.  MBC is the lowest concentration of propolis required to kill F. nucleatum.  
MIC and MBC were tested using concentrations within a range of previous study 
findings
109,111,140-143
 and adjusted as needed to exemplify a range of possible 
concentrations using a two-fold dilution method.  An overnight culture of F. nucleatum 
grown in 5 ml of BHI-YE (with 5.0-percent v/v hemin/vitamin K) will be treated with 
50,000 μg/ml, 25,000 μg/ml, 12,500 μg/ml, 6250 μg/ml, 3125 μg/ml, 1562.5 μg/ml, 
781.25 μg/ml, and 390.625 μg/ml of propolis in BHI-YE (with 5.0-percent v/v 
hemin/vitamin K) for 48 hours in sterile 96-well flat-bottom microtiter plates (Fischer 
Scientific, Newark, DE) (see Figure 10).
142-146
   Propolis dissolved in DMSO to its stock 
concentration of 100,000 μg/ml will be further diluted using the same two-fold dilution 
method with BHI-YE (with 5.0-percent v/v hemin/vitamin K) to achieve these 
concentrations (see Figure 8).  The experimental test groups will be inoculated with F. 
nucleatum in volume ratios of 190:10 μl BHI-YE/propolis:F. nucleatum. Each test 
concentration will have four wells to enable quadruplicate evaluation per each trial. Each 
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test concentration of propolis will have its own quadruplicate negative control wells 
containing 200-μl BHI-YE/propolis with no addition of F. nucleatum. Three trials were 
conducted for this study. 
The optical density values of the bacterial cultures will be measured at 595 nm in 
a spectrophotometer (SpectraMax 190; Molecular Devices, Sunnyvale, CA) (see Figure 
11) on the setting with no pre-mix for the total (biofilm and planktonic) reading. To 
determine the MIC the lowest concentration of propolis that provided no significance in 
total growth was reported. To determine the MBC F. nucleatum cultures from the wells 
with propolis concentrations equal to or higher than the MIC will be transferred onto 
blood agar plates and incubated for 48 hours. The MBC will be determined as the 
minimum concentration of propolis that is bactericidal after 48 hours of incubation.
138
 
 
MINIMUM BIOFILM INHIBITORY CONCENTRATION (MBIC) 
 The MBIC is the lowest concentration of propolis that is required to inhibit 
visible F. nucleatum biofilm formation. The quantification of microbial biofilm grown in 
96-well microtiter plates has been described as an approach to studying biofilm 
performed in previous studies
138,141,144,147-150
 as well as in the endodontic literature.
151
  It 
has been a published method of F. nucleatum biofilm evaluation in the oral microbiology 
literature.
144
  F. nucleatum biofilm will be formed within 96-well microtiter plates
146
 by 
allowing bacterial growth and biofilm adherence to well walls.
145
  Propolis will be added 
simultaneously at the time of inoculation of the wells
142
 to evaluate the influence of 
propolis on inhibition of new biofilm formation within the wells. F. nucleatum will be 
treated as previously mentioned in the MIC/MBC description. Once the total (planktonic 
and biofilm) reading has been performed by the spectrophotometer, 10 μl samples from 
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each concentration will be taken to be used for the MBC test and 120 μl will be 
transferred to a nonsterile 96-well plate to read the planktonic values with the 
spectrophotometer at 595 nm on the 5-second pre-mix setting.  The remaining 80 μl will 
be discarded followed by washing the wells twice with 200 μl of sterile saline and fixed 
with 200 μl of 10.0-percent formaldehyde.  After a 30-minute period of fixation the wells 
will be washed three times with deionized water and stained with 200 μl of 0.5-percent 
crystal violet for 30 minutes.  After 30 minutes the wells will be washed three times with 
deionized water.  Next, crystal violet will be extracted from the biofilm cells by 
incubation for 30 minutes with 200 μl of 2-propanol. The absorbance will be read at 490 
nm on the 5-second pre-mix setting with quadruplicate wells of 2-propanol used as the 
blank control.
138
 
 
STATISTICAL ANALYSES 
Four wells on each plate were used for each study group (positive control and 8 
propolis levels) and for negative controls for each group (media with no bacteria with the 
corresponding level of propolis). The average of the four wells for the negative controls 
was subtracted from the average for four wells for each group. The experiment was 
repeated three times. Comparisons for each group against its corresponding negative 
control were made using paired t-tests. Group comparisons were performed using one-
way ANOVA, followed by pair-wise comparisons among groups using Tukey’s method 
to control the overall significance level at 5 percent.  
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RESULTS 
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The results of the total containing biofilm and planktonic components were as 
follows (see Graph 3): Positive control, Propolis 390.625 μg/ml, Propolis 781.25 μg/ml, 
Propolis 1562.5 μg/ml, and Propolis 3125 μg/ml had significantly higher absorbance than 
their negative controls.  Positive control, Propolis 390.625 μg/ml; Propolis 781.25 μg/ml; 
Propolis 1562.5 μg/ml were significantly higher than Propolis 12,500 μg/ml; Propolis 
25,000 μg/ml; and Propolis 50,000 μg/ml (p < 0.01); while Propolis 3125 μg/ml and 
Propolis 6250 μg/ml were significantly higher than Propolis 50,000 μg/ml (p ≤ 0.01). 
The planktonic results were as follows (see Figure 4): Propolis 25,000 μg/ml and 
50,000 μg/ml had significantly lower absorbance than their negative controls. There were 
no significant differences among groups (p = 0.11). 
The biofilm results were as follows (see Figure 6): Values for the propolis 
390.625 μg/ml and 781.25 μg/ml groups had significantly higher absorbance (p < 0.05) 
than their negative controls. There were no significant differences among groups (p = 
0.28). 
The results show that the MIC of the total (biofilm + planktonic) appears to occur 
at a concentration of 6250 μg/ml.  The MBIC appears to occur at the concentration of 
1562.5 μg/ml.  The planktonic results exhibit no significant difference in test and control 
wells that would imply bacterial growth; rather, they merely exhibit this at the highest 
concentrations of propolis. The additional 10 μl of propolis-containing media rather than 
10 μl of bacterial suspension may cause a more dense solution. There was no MBC at any 
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of the test concentrations. The propolis appears to inhibit bacterial growth and biofilm 
formation, but does not appear to be bactericidal at any of the tested concentrations. 
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FIGURE 1.  Average absorbance of total (planktonic + biofilm) test (propolis  
with F. nucleatum) and control (propolis with no F. 
nucleatum) wells. These values were used to compare the  
 differences in absorbance.  Note the wells with F. nucleatum show 
significant bacterial growth at 0, 390, 780.2, and 1562.5 and 3,125 μl. 
These values represent the mean of quadruplicate wells in each  of 
three trials. 
 
 
 
41 
 
 
FIGURE 2.  Effect of propolis on Fusobacterium nucleatum total (biofilm + 
planktonic) growth.  Absorbance is shown as the differencbetween 
absorbance of the test wells with F. nucleatum and that of the negative 
control wells with propolis. The MIC was determined to be 6250 μg/ml 
as concentrations below this showed significant bacterial growth. The * 
symbol indicates significant difference in  absorbance (significant 
bacterial growth). 
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     FIGURE 3. Average absorbance of planktonic test and control wells. Note the  
absorbance of the test wells with F. nucleatum in the planktonic  form 
show less absorbance than the control wells.This was attributed to the 
variation of 10 μl of bacteria present in the test wells versus an 
additional 10 μl of the diluted propolis solution in  the control wells 
(propolis contributes greater absorbance). There were no significant 
differences in absorbance between test and control wells. These values 
represent the mean of quadruplicate wells in each of three trials. 
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      FIGURE 4. Effect of propolis on Fusobacterium nucleatum planktonic growth.  
Absorbance is shown as the difference between absorbance of the test 
wells with F. nucleatum and that of the individualized negative  control 
wells with propolis. No MIC was found for the planktonic component 
as no test wells showed significantly greater absorbance when 
compared to their individualized control wells. The absorbance 
difference appears as negative values presumably due to the greater 
absorbance of the additional 10 μl of propolis in the control wells 
versus the 10 μl of bacteria in the test wells. 
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FIGURE 5. Average absorbance of total (planktonic + biofilm) test 
and control wells. Note the wells with F. nucleatum 
showed significant bacterial growth at 0, 390 and 780.2. 
The higher absorbance at 3125 μg/ml was due to an 
outlier at this concentration that was included for 
comprehensive statistical analysis. These values 
represent the mean of quadruplicate wells in each of three 
trials. 
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FIGURE 6. Effect of propolis on F. nucleatum biofilm growth. Absorbance 
difference is the difference between absorbance of the test wells with F. 
nucleatum and that of the individual negative control wells with 
propolis. The MBIC was determined to be 1562.5 μg/ml as 
concentrations below this showed significant bacterial growth. The * 
symbol indicates no significant difference in absorbance (no significant 
bacterial growth). 
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      FIGURE 7.    Lack of effect of DMSO on bacterial growth. All or nothing visible 
turbidity was examined. Turbidity (bacterial growth) was visible up 
until 25% DMSO. This DMSO concentration coincided in our study 
with the 25,000 μg/ml of propolis solution. The occurrence of the 
propolis MIC and MBIC at concentrations of DMSO that did not show 
bacterial inhibition exemplify the antimicrobial effect of propolis. 
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      FIGURE 8.    Commercial propolis from Ecuadorian Rainforest L.L.C.   
 Note: 500-g bag this study utilized <2 g of propolis (0.25g/25ml for 
10,000 μg/ml solution and 1.0g/10 ml for 100,000 μg/ml solution). 
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FIGURE 9.   All pipette work performed adjacent to Bunsen burner on bench top to  
  minimize bacterial contamination; also used to flame cervical area of  
  containers prior to removing solutions with pipette. 
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FIGURE 10. Pipettes – 200 μl and 1000 μl. 
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FIGURE 11. F. nucleatum plate and loop. 
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 FIGURE 12. Gaspak Jar with F. nucleatum growing in  
        sterile tube  between day one and day two. 
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 FIGURE 13. F. nucleatum turbid tube shows growth 
   after 24-h incubation at 37
o
C in BHI/Vit. K/hemin   
  media.Ten μl from this tube was transferred to 
   each test well and the positive control wells. 
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  FIGURE 14. Day two: propolis dilution tubes – dilutions from 50,000 to 390.625 μg/ml. 
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FIGURE 15. Incubator – 37oC with Gaspak jars inside. 
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 FIGURE 16.  Gaspak jar with propolis and  
                   F. nucleatum in 96-well microplate incubating 
        between day two and experimental 
             day three (48 hours later). 
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FIGURE 17.  Spectrophotometer (SpectraMax 190; Molecular Devices, Sunnyvale, CA). 
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FIGURE 18. Template setup to match the 96-well plate solutions. 
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FIGURE 19.  The bottle on the right shows contaminated BHI/Vit.K/hemin from   
            experiment four (turbidity in the bottle on the right compared to the  
            bottle on the left with no turbidity). 
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  FIGURE 20.  Closer examination of the turbidity shows 
              bacterial colonization in contaminated 
              BHI/Vit.K/hemin from experiment four. 
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FIGURE 21.  Contaminated experiment four 96-well plate. Almost 
            all wells show turbidity representing contamination (including  
            most of the negative controls containing propolis and the negative                   
            control of BHI-YE/vitK/hemin broth alone – exemplifying contamination    
            of the broth). 
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FIGURE 22.  Contaminated experiment five – the negative control wells and 
 lowest concentration of propolis wells show no turbidity – 
 confirming no contamination of the broth and exemplifying 
 contamination of the propolis stock solution. 
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      FIGURE 23. Experiment nine – successful controls and bacterial growth as 
expected (A1-D1 positive control; E1-H1 negative control; A-D:2-9 
test wells; E-H:2-9 control wells).  Propolis concentrations were as 
follows: column 2: 390.625μg/ml; column 3: 781.25 μg/ml; column 4: 
1562.5 μg/ml; column 5: 3125 μg/ml; column 6:6250 μg/ml; column 
7: 12,500 μg/ml; column 8: 25,000 μg/ml; column 9: 50,000 μg/ml. 
Note in the test wells the similar density of staining in the lowest 
concentrations of propolis comparable to the positive control well 
(indicative of too low of a concentration to be inhibitory). As 
concentration reaches 1562.5 μg/ml turbidity decreases and becomes 
apparently consistent with extent of turbidity in relative negative 
control wells. The decrease in density due to bacterial biofilm 
inhibition is countered by an increase in density due to the density of 
the propolis (hence the need for spectrophotometer readings to 
compare each test group to a propolis concentration relative negative 
control group). Note in the control and test wells as concentration of 
propolis increased up to 6250 to 12,500 μg/ml the density of propolis 
staining in the wells increased and had an interesting (and consistent in 
all three trials) decrease in staining at 25,000 μg/ml and 50,000 μg/ml. 
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FIGURE 24. Note the visible precipitation of propolis in column 6 (6250 μg/ml; 
arrow)  representative of the previously mentioned signs of the peak 
absorbance of propolis at 6250 to 12,500 μg/ml. 
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FIGURE 25.    MBC blood agar plate shows growth of F. nucleatum at all tested  
  concentrations (although appears to have a decreased ability to flourish at  
  higher propolis concentrations) and confirmed no growth in the negative  
  control of broth and negative control with propolis. 
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FIGURE 26. In order to verify the DMSO was not functioning as the 
 antimicrobial in the wells, a control test of all concentrations of 
 DMSO used was performed. Propolis was not included in this 
 experiment.  The DMSO concentrations by volume in each well 
 were diluted with BHI:YE/vitamin K/hemin to achieve: 
 50%, 25%, 12.5%, 6.25%, 3.125%, 1.56% and 0.78%.  
  Above is the view of the plate prior to incubation. 
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FIGURE 27.   Above is a photo of the turbidity seen in the evaluation of the  
 antimicrobial efficacy of DMSO.  Propolis was not included in 
  this experiment. Consistent visual turbidity indicative of 
 bacterial growth was seen in quadruplicate of all test 
 concentrations except  at the highest two concentrations of 25-
 percent and 50-percent DMSO. The propolis MBIC and MIC 
 concentrations are noted as a reference for comparison. 
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The first five experiments as well as experiment number eight could be 
considered a series of pilot studies and provide adjunctive information regarding a target 
concentration range of propolis/DMSO:BHI-YE, incubation time evaluation as well as 
determine the need to filter the propolis stock solution.  It is noteworthy that during the 
initial experimentation without contamination of the initial stock solution, the MIC value 
appeared within a close estimated range to the final determined MIC concentration.  This 
was interesting as it provides additional information of an estimated concentration at 
which propolis appears to be antimicrobial under these experimental conditions. 
Using the information provided by the DMSO control study, the pilot study, and 
the triplicate experimental studies, it was confirmed that the propolis appears to be acting 
as an antimicrobial agent.  If DMSO were acting as the antimicrobial, there would have 
been more inhibition of microbial growth in the pilot study at coinciding concentrations 
of DMSO to the final studies.  Additionally, experiment eight which had an extended 96 
hour incubation period provided similar data regarding the MIC/MBIC values coinciding 
the the propolis concentrations.  Ultimately, the DMSO control study provided evidence 
that the DMSO did not have an antimicrobial effect at the concentrations at which the 
propolis inhibition of bacteria occurred. 
In the DMSO control study, DMSO appeared to have an antimicrobial effect only 
at concentrations of 25-percent and 50-percent DMSO (see Figure 20 and 21), which in 
the triplicate experimental studies coincided with the 50,000 μg/ml and 25,000 μg/ml of 
propolis.  Since the MIC and MBIC were determined to be at concentrations of 6250 
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μg/ml and 1562.5 μg/ml respectively, there is confirmed antimicrobial activity occurring 
prior to the DMSO has a profound effect. One could question whether DMSO may have a 
synergistic effect to increase the ability of the propolis to be a better antimicrobial.  This 
is a valid question as Douwes et al. noted that DMSO may enhance the effect of other 
drugs.
152
  Previous studies have used DMSO as a solvent for antimicrobial testing.  
Cuenca-Estrella used DMSO with stock solutions of antimicrobials starting at 100 times 
the concentration of that being evaluated within microtiter wells. They described that 
susceptibility testing standards recommend a series of dilutions from a stock solution to 
avoid dilution artifacts from precipitation of the test compound.
153
  This description 
exemplifies that other researchers have also found precipitation of medicaments within 
microtiter wells as we noted at certain concentrations within our experimental results. 
One of the interesting findings consistent in the three trials used (experiment six, 
seven, and nine), as well as seen in the additional unused trial (experiment eight) was the 
amount of precipitate noted at each diluted concentration of propolis (see Figure 18).  It 
appeared consistent that the greatest amount of precipitation of propolis in the microtiter 
plate wells occurred at a concentration of 6250 to 12,500 μg/ml.  Only speculation can be 
provided at this point why at the concentrations of 25,000 and 50,000 μg/ml of propolis  
adhered (formed precipitate along the well walls) less to the microtiter plate wells.  One 
hypothesis could be that once the propolis concentration reaches a certain upper 
threshold, the viscosity of the solution prevents precipitate formation along the well 
walls.  This may be due to an effect with the DMSO, as the highest two concentrations 
examined appear to show the most evident decrease in biofilm or propolis adherence to 
the wells.  It appears that biofilm adheres to the wells best prior to the MIC/MBIC of 
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propolis, followed by propolis precipitation onto the wells past the MIC/MBIC, followed 
by less adherence of either at the highest concentrations of propolis/DMSO.  There is 
potential that at the highest concentration of solvent, the propolis remains soluble and 
does not precipitate as easily.   
Further description of this hypothesis is as follows: Propolis may be inhibiting 
aggregation of bacterial cells by inhibition of their outer membrane proteins or through 
quorum sensing, which may additionally be involved in adherence to other cells as well 
as the plate wells.  At low concentrations, the propolis does not block enough outer 
membrane proteins or reduce quorum-sensing activity to disrupt coaggregation and 
biofilm adherence to the wells and there is not a high enough concentration of propolis 
particulate to leave a residue along the surface area of the wells; therefore, biofilm forms 
along the wells and not propolis particulate.  At moderate concentrations, propolis 
inhibits the interactions of outer membrane proteins or inhibits quorum-sensing, thus it 
disrupts biofilm formation and bacteria adherence to the wells leaving more surface area 
of the wells for propolis particulate to precipitate onto.  Therefore, there is less/no biofilm 
adhering to the surface area of the well walls and there is high enough concentration 
(with less concentrated solvent) of the propolis to leave particulate matter to precipitate 
onto the surface area of the wells.  As the propolis concentration rises to higher 
concentrations, the propolis continues to inhibit biofilm adherence to the wells and there 
is a high enough concentrate of DMSO to keep the propolis soluble and remain 
suspended in the solution rather than precipitating onto the walls of the well. 
Regarding previous publications of inhibitory concentrations of propolis, 
comparable methods to ours have been used.  The use of the 96-well microtiter plate 
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method has been demonstrated in previous studies such as when Dziedzic et al. 
performed their MIC/MBC test of propolis on mutans streptococci and lactobacilli in 96-
well microtiter plates using spectroscopic analysis at 600 nm.
112
  Moncla et al. in 2012 
found an MIC of 1600 μg/ml when tested against Enterococcus species. Using an agar 
dilution method, they tested human and animal isolates of Enterococci and found that 
human isolates of E. faecium and  E. faecalis from refractory endodontic treatment cases 
were particularly susceptible to Brazilian propolis.
14
  This MIC is a close approximation 
to our MIC value determined for F. nucleatum (6,250 μg/ml).  Using a macrodilution 
method with an ethanol extract of propolis, Uzel et al. found the MIC of propolis of 
varying bacteria (staphylococcus, streptococcus, enterococcus, pseudomonas, salmonella) 
to be in a range of 2 to 32 μg/ml.109  Using an agar dilution method, Koru et al. found that 
propolis samples were more effective against Gram positive anaerobic bacteria than 
Gram negatives when using an ethanol extract of propolis.  They found MIC ranges from 
4 to 512 μg/ml and MBC ranges from 8 to 512 μg/ml.143  Dziedzic et al. as mentioned 
earlier, used a broth diffusion method and AlamarBlue assay and found the MIC for 
mutans streptococci to be 1100  mg/ml and the MBC to be 9010  mg/ml as well as the 
MIC for lactobacilli to be 700  mg/ml and the MBC to be 5910  mg/ml.112  Arslan et al. 
used an ethanol extract of propolis in a macrobroth dilution method and found MIC and 
MBC antibacterial activity against E. faecalis and C. albicans in a concentration range 
from 2 to 2400 mg/ml.
15
  Ghasem et al. found MIC values in weight per volume ratios for 
different propolis samples against S. aureus and C. albicans using an ethanol extract of 
propolis and a Petri dish bioassay method.
16
  These studies and our own results reproduce 
data that consistently reveal that propolis may have a reasonably predictable MIC when 
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tested among a variety of microorganisms. Although the literature reveals that propolis 
has a reasonably predictable MIC range when tested among a variety of methods (agar 
dilution versus microtiter plate wells), using varying solvents (ethanol extract versus 
DMSO), and among a wide range of bacteria, the results from one method cannot be 
directly correlated or compared to that of another.  Additionally, serial dilution methods 
have shown to provide more consistent results and microdilution methods have been 
utilized in a variety of studies to evaluate the antimicrobial effectiveness of propolis.
140
  
Interestingly, several studies presented a MBC value for propolis including one 
for F. nucleatum.
143
  In our study, we were unable to produce a MBC even when no 
suspicion of contamination was confirmed with negative control tests (see Figure 19).  
This is noteworthy because it does not agree with previous literature evaluating the 
antimicrobial properties of propolis.  Several hypotheses will be presented of potential 
reasons why this finding may have occurred. 
One hypothesis is that many other previous studies used an ethanol extract of 
propolis and this extraction process may free up more of the active antimicrobial 
components of propolis such as the flavonoids and flavonones.  Macedo et al. stated, 
“Several herbal, animal and microbial extracts possess quorum-quenching activity but 
few active compounds and synthetic analogues are known.”137  It is possible that through 
the extraction process the compound availability is altered to enhance the antimicrobial 
effect.  Similarly, the use of a commercially available formulation of propolis may 
exemplify variable antimicrobial properties. 
Although there was no MBC, there appears to be a decreased ability of F. 
nucleatum to flourish at higher propolis concentrations. This was visually evaluated by 
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the less abundant growth seen on blood agar plates used to determine MBC at higher 
propolis concentrations. The discrepancy between previous studies and the current study 
may be due to the materials or methods involved in MBC examination. Several studies 
have described MBC as the ability to kill 50 percent of the bacteria.  This may have 
allowed them to consider an MBC at a value that we did not consider as an MBC because 
our study was considering an MBC to be 100-percent MBC.  
Another hypothesis to why there has been shown to be an MBC in previous 
studies and not in ours is that not all strains of F. nucleatum may respond the same to 
medicaments.  It has been noted that “important concentrations are necessary to inhibit 
growth of some F. nucleatum strains. In the study by Joly et al., concentrations of 250 
μg/ml are not sufficient to inhibit growth of some strains, but other strains are very 
sensitive.”123,154  Thus the use of strain ATCC 10953 in this study may provide variable 
results compared to other previous studies. 
Another hypothesis to why propolis shows an MIC and MBIC with no MBC may 
be that propolis inhibits adherence to the microtiter plate well walls.  This has been a 
proposed alternative method to fight biofilm infections; rather than destroy the microbes 
with antimicrobials, generate a functional surface to prevent the attachment of bacteria.
135
  
 Another hypothesis to why propolis shows an MIC and MBIC with no MBC is 
that propolis inhibits biofilm development or growth and inhibits the interaction or 
further replication of the bacteria. It may do so by interference with the outer membrane 
proteins or by interfering with quorum sensing. As previously described, propolis has 
shown anti-quorum sensing activity. Bulman et al. found propolis to contain compounds 
that suppress the quorum-sensing response. Our study may be exemplifying this anti-
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quorum sensing effect.
107
  By interfering with outer membrane proteins, such as those 
responsible for either producing the quorum-sensing molecule or the receptor that binds 
it, it may be reducing the aggregation of the bacteria and attach to the well walls or to 
each other.  By interfering with quorum sensing, it may be disallowing bacteria to 
aggregate in a structural and functional manner that is necessary for them to thrive as a 
biofilm.  Previous literature has stated that “several herbal, animal and microbial extracts 
possess quorum-quenching activity.”137  This could be one of the mechanisms by which 
the antimicrobial extracts of propolis function. Therefore, propolis may exhibit inhibitory 
effects within the experimental design, yet it may not be bactericidal under these 
experimental conditions.   
One of the most interesting findings of this study was that the results indicate 
there is potentially significant interaction of propolis with biofilm.  This was displayed by 
three main points within the study.  First, the lower concentration needed to exhibit 
inhibitory effects on biofilm formation (1562.5 μg/ml) in comparison to the MIC of the 
total planktonic + biofilm (6250 μg/ml).  This allows speculation that within the total 
MIC and the MBIC evaluation it appears that the biofilm inhibition is more likely what is 
being inhibited.  Second, this indication is further exemplified by the lack of microbial 
inhibition seen in the planktonic evaluation. If propolis was acting on individual cells or 
cells in the planktonic form, one would expect to see a MIC in the planktonic evaluation 
which did not occur. Third, there was no MBC detected. If propolis inhibits biofilm 
formation or cell aggregation, it may not be cytotoxic to cells plated on growth media, 
which allows them to replicate. This may be evidence that the biofilm inhibitory effect is 
most profound on diminishing the ability for attachment to the well wall surface. 
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For the evaluation of biofilm under in-vitro experimental conditions, a variety of 
methods exist such as the microtiter plate method, tube test, radiolabeling, microscopy, 
and the Congo red agar plate test.  The microtiter plate method is one of the most 
frequently used assays.
147
  The quantification of microbial biofilm grown in 96-well 
microtiter plates has been described as an approach to studying biofilm and has been 
performed in previous studies.
138,141,147,149,150,155
 It has been a published method of F. 
nucleatum biofilm evaluation in the oral microbiology literature.
144
  It is understood that 
biofilm may adhere to non-biologic surfaces (such as the polystyrene of the microtiter 
plate) as one author defined biofilms as “matrix-enclosed microbial accretions 
(aggregations) that adhere to biological or non-biological surfaces.”135,136  The microtiter 
plate method was selected due to its ability to serve as a “rapid screening method 
sensitive enough to elucidate concentration-response relationships as well as differences 
between species responses to treatments.”156  Regarding the complexity of F. nucleatum 
biofilm growth in vitro, in one study biofilm forming ability was evaluated in 20 strains 
of bacteria common to apical periodontitis and F. nucleatum exhibited the strongest 
adherence to type-I collagen-coated polystyrene microplates
144
 in methods that are 
similar to ours.  Additionally, in a study published in the Journal of Endodontics testing a 
medicament’s antibacterial effect on F. nucleatum biofilm, the authors used 24-well 
polystyrene TC plates. The authors of this study confirmed the attachment of bacteria on 
polystyrene, by using an extra set of biofilms grown and checked by light absorbance 
readings in a microplate spectrophotometer at 540-nm wavelength after staining with 
crystal violet.
145
  Bachrach et al. used F. nucleatum in a microtiter plate coaggregation 
assay and found it to be sensitive and reproducible using 96-well microtiter plates.
146
  In 
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our study we made no additional efforts to confirm the true attachment of bacteria or 
biofilm to the microtiter plates. The length of time it takes for biofilm formation to occur 
is for discussion. Previous studies have described inoculation of wells for a period of 2 
days,
144
 16 hours,
146
 or testing performed at time periods of 24 and 96 hours for 
biofilm,
145
 or observed death of F. nucleatum.
143
  We performed our experimental 
conditions under similar circumstances as previously published studies; therefore, we 
made no effort to confirm there was true biofilm formation in the sense of its proper 
definition. The previously mentioned publications appear to support the use of the 
microtiter plate method for the evaluation of the efficacy of propolis on the inhibition of 
F. nucleatum biofilm under circumstances similar to our study. 
An additional question that was raised was whether DMSO could have had a 
contributory antimicrobial effect. DMSO at certain concentrations is known to be 
antimicrobial.
157
  Previous studies of propolis have used DMSO, one which stated that 
concentrations below 5.0-percent DMSO have no antimicrobial contribution.
140,141
  The 
DMSO trial performed to examine each individual concentration of DMSO used in the 
study confirmed bacterial growth at concentrations that showed inhibition when propolis 
was added.  This confirmed that DMSO had no significant antimicrobial effect.  
Additionally, several initial pilot studies confirmed that DMSO had no significant 
antimicrobial effect.  It showed that at very low concentrations of propolis (which were 
shown by our triplicate studies to not be high enough to be antimicrobial), even with 
higher concentrations of DMSO, there was no antimicrobial effect being seen by DMSO.  
Interestingly, DMSO has been described to have the ability to potentiate the effects of 
other drugs.
152
  It is possible that although the DMSO does not appear to have an 
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antimicrobial effect, it may enhance the antimicrobial activity of propolis. This may be 
evident by comparison with a future similar study that is planned to take place at the 
same institution (Indiana University). 
In the fourth and fifth experiments it was confirmed that the stock solution of 
propolis was contaminated (see Figure 13 to 16).  No culture examination was performed 
to determine which microorganisms were present as the contaminants. Turbiditiy was 
seen in the broth used initially during experiment four. Experiment five confirmed using 
new broth and control wells that the stock solution of propolis was the source of 
contamination. Filter sterilization of the stock solution was performed prior to further 
experimentation, and control wells with each experiment confirmed there was no further 
contamination. 
Future studies could be performed to examine a clinically applicable media that 
could be used as a carrier for intracanal medication, such as propylene glycol.  
Additionally, using the commercial formulation of propolis, there may be benefit to using 
higher concentrations to enable a slurry mix of the propolis powder rather than 
attempting to dissolve it. Furthermore, the use of propolis in nature is as a sealant for 
beehives. Consideration of testing propolis in a form that may allow it to “set” as it does 
in nature to create an antimicrobial seal may be of more benefit in endodontics as a sealer 
than its use as an intracanal medication. 
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SUMMARY AND CONCLUSIONS 
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The results indicate that the MIC of the total (biofilm+planktonic) appears to 
occur at a concentration of 6250 μg/ml.  The MBIC was established at 1562.5 μg/ml.  
The planktonic results exhibited no significant difference in test and control wells. There 
was no MBC at any of the test concentrations. Propolis appears to inhibit bacterial 
growth and biofilm formation but does not appear to be bactericidal at any of the tested 
concentrations.   
The results of this study indicate that propolis has an MIC and MBIC when tested 
in vitro against F. nucleatum, although it does not show an MBC. There appears to be a 
potentially significant interaction of propolis with biofilm as displayed by the lower 
concentration needed to exhibit inhibitory effects on biofilm formation. This information 
may contribute to the ability to develop a proper concentration of propolis to use in vivo 
when treating endodontic infections. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
 
 
 
 
 
 
81 
 
 
 
1. Kakehashi S, Stanley HR, Fitzgerald RJ. The effects of surgical exposures of 
dental pulps in germ-free and conventional laboratory rats. Oral Surg Oral Med 
Oral Pathol 1965;20:340-9. 
2. Spångberg LSW, Haapasalo M. Rationale and efficacy of root canal medicaments 
and root filling materials with emphasis on treatment outcome. Endod Topic 
2002;2:35-58. 
3. Wilbrand JF, Wilbrand M, Schaaf H, Howaldt HP, Malik CY, Streckbein P. 
Embolia cutis medicamentosa (Nicolau syndrome) after endodontic treatment: a 
case report. J Endod 2011;37:875-7. 
4. Madhubala MM, Srinivasan N, Ahamed S. Comparative evaluation of propolis 
and triantibiotic mixture as an intracanal medicament against Enterococcus 
faecalis. J Endod 2011;37:1287-9. 
5. Safavi KE, Spangberg LS, Langeland K. Root canal dentinal tubule disinfection. J 
Endod 1990;16:207-10. 
6. Sjogren U, Figdor D, Spangberg L, Sundqvist G. The antimicrobial effect of 
calcium hydroxide as a short-term intracanal dressing. Int Endod J 1991;24:119-
25. 
7. Farhad A, Mohammadi Z. Calcium hydroxide: a review. Int Dent J 2005;55:293-
301. 
8. Haapasalo M, Orstavik D. In vitro infection and disinfection of dentinal tubules. J  
Dent Res 1987;66:1375-9. 
9. Waltimo T, Trope M, Haapasalo M, Orstavik D. Clinical efficacy of treatment 
procedures in endodontic infection control and one year follow-up of periapical 
healing. J Endod 2005;31:863-6. 
10. Siqueira JF, Jr., de Uzeda M. Disinfection by calcium hydroxide pastes of 
dentinal tubules infected with two obligate and one facultative anaerobic bacteria. 
J Endod 1996;22:674-6. 
11. Estrela C, Sydney GB, Figueiredo JA, Estrela CR. Antibacterial efficacy of 
intracanal medicaments on bacterial biofilm: a critical review. J Appl Oral Sci 
2009;17:1-7. 
12. Bolstad AI, Jensen HB, Bakken V. Taxonomy, biology, and periodontal aspects 
of Fusobacterium nucleatum. Clin Microbiol Rev 1996;9:55-71. 
82 
 
13. Awawdeh L, Al-Beitawi M, Hammad M. Effectiveness of propolis and calcium 
hydroxide as a short-term intracanal medicament against Enterococcus faecalis: a 
laboratory study. Aust Endod J 2009;35:52-8. 
14. Moncla BJ, Guevara PW, Wallace JA, Marcucci MC, Nor JE, Bretz WA. The 
inhibitory activity of typified propolis against Enterococcus species. Z 
Naturforsch C 2012;67:249-56. 
15. Arslan S, Ozbilge H, Kaya EG, Er O. In vitro antimicrobial activity of propolis, 
BioPure MTAD, sodium hypochlorite, and chlorhexidine on Enterococcus 
faecalis and Candida albicans. Saudi Med J 2011;32:479-83. 
16. Ghasem YB, Ownagh A, Hasanloei M. Antibacterial and antifungal activity of 
Iranian propolis against Staphylococcus aureus and Candida albicans. Pak J Biol 
Sci 2007;10:1343-5. 
17. Siqueira JF, Jr., Rocas IN, Alves FR, Silva MG. Bacteria in the apical root canal 
of teeth with primary apical periodontitis. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod 2009;107:721-6. 
18. Chugal N, Wang JK, Wang R, et al. Molecular characterization of the microbial 
flora residing at the apical portion of infected root canals of human teeth. J Endod 
2011;37:1359-64. 
19. Tagger M. Endodontics: a review of the past and is present status. Alpha Omegan 
1967;60:107-18. 
20. Cruse WP, Bellizzi R. A historic review of endodontics, 1689-1963 (Pt 1). J 
Endod 1980;6:495-9. 
21. Cruse WP, Bellizzi R. A historic review of endodontics, 1689-1963 (Pt 2). J 
Endod 1980;6:532-5. 
22. Dakin HD. On the use of certain antiseptic substances in the treatment of infected 
wounds. Br Med J 1915;2:318-20. 
23. Bellizzi R, Cruse WP. A historic review of endodontics, 1689-1963 (Pt 3). J 
Endod 1980;6:576-80. 
24. Anthony LP, Grossman, L.I. A brief history of root canal therapy in the United 
States. J Am Dent Assoc 1945;32:43-50. 
25. Reimann HA HW. Focal infection and systemic disease: a critical appraisal: the 
case against indiscriminate removal of teeth and tonsils clinical lecture at St. 
Louis Session. JAMA 1940;114:1-6. 
26. Siqueira JF, Jr. Endodontic infections: concepts, paradigms, and perspectives. 
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:281-93. 
83 
 
27. Glick DH. Endodontics: past, present and future. Alpha Omeg 1968;61:124-6. 
28. Hargreaves KM, Cohen S, Berman LH. Cohen's pathways of the pulp. 10th ed. St. 
Louis: Mosby Elsevier; 2011. 
29. Moller AJ, Fabricius L, Dahlen G, Ohman AE, Heyden G. Influence on periapical 
tissues of indigenous oral bacteria and necrotic pulp tissue in monkeys. Scand J 
Dent Res 1981;89:475-84. 
30. Saboia-Dantas CJ, Coutrin de Toledo LF, Sampaio-Filho HR, Siqueira JF, Jr. 
Herpesviruses in asymptomatic apical periodontitis lesions: an 
immunohistochemical approach. Oral Microbiol Immunol 2007;22:320-5. 
31. Slots J, Sabeti M, Simon JH. Herpesviruses in periapical pathosis: an 
etiopathogenic relationship? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
2003;96:327-31. 
32. Siqueira JF, Jr., Sen BH. Fungi in endodontic infections. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod 2004;97:632-41. 
33. Vianna ME, Conrads G, Gomes BP, Horz HP. Identification and quantification of 
archaea involved in primary endodontic infections. J Clin Microbiol 
2006;44:1274-82. 
34. Stewart G. The importance of chemomechanical preparation of the root canal. 
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1955;8:993-7. 
35. Nerwich A, Figdor D, Messer HH. pH changes in root dentin over a 4-week 
period following root canal dressing with calcium hydroxide. J Endod 
1993;19:302-6. 
36. Kuttler Y. Microscopic investigation of root apexes. J Am Dent Assoc 
1955;50:544-52. 
37. Meder-Cowherd L, Williamson AE, Johnson WT, Vasilescu D, Walton R, Qian 
F. Apical morphology of the palatal roots of maxillary molars by using micro-
computed tomography. J Endod 2011;37:1162-5. 
38. Hassanien EE, Hashem A, Chalfin H. Histomorphometric study of the root apex 
of mandibular premolar teeth: an attempt to correlate working length measured 
with electronic and radiograph methods to various anatomic positions in the 
apical portion of the canal. J Endod 2008;34:408-12. 
39. Green D. Stereomicroscopic study of 700 root apices of maxillary and mandibular 
posterior teeth. Oral Surg Oral Med Oral Pathol 1960;13:728-33. 
84 
 
40. Weine FS, Healey HJ, Gerstein H, Evanson L. Canal configuration in the 
mesiobuccal root of the maxillary first molar and its endodontic significance. Oral 
Surg Oral Med Oral Pathol 1969;28:419-25. 
41. Weine FS, Healey HJ, Gerstein H, Evanson L. Canal configuration in the 
mesiobuccal root of the maxillary first molar and its endodontic significance. J 
Endod 2012;38:1305-8. 
42. Gilles J, Reader A. An SEM investigation of the mesiolingual canal in human 
maxillary first and second molars. Oral Surg Oral Med Oral Pathol 1990;70:638-
43. 
43. Verma P, Love RM. A Micro CT study of the mesiobuccal root canal morphology 
of the maxillary first molar tooth. Int Endod J 2011;44:210-7. 
44. de Pablo OV, Estevez R, Heilborn C, Cohenca N. Root anatomy and canal 
configuration of the permanent mandibular first molar: clinical implications and 
recommendations. Quintessence Int 2012;43:15-27. 
45. Vertucci F, Seelig A, Gillis R. Root canal morphology of the human maxillary 
second premolar. Oral Surg Oral Med Oral Pathol 1974;38:456-64. 
46. Spangber.L, Engstrom B, Langelan.K. Biologic effects of dental materials .3. 
toxicity and antimicrobial effect of endodontic antiseptics in vitro. Oral Surg Oral 
Med Oral Pathol Oral Radiol Endod 1973;36:856-71. 
47. Bystrom A, Sundqvist G. Bacteriologic evaluation of the efficacy of mechanical 
root-canal instrumentation in endodontic therapy. Scand J Dent Res 1981;89:321-
8. 
48. Bystrom A, Sundqvist G. Bacteriologic Evaluation of the effect of 0.5 percent 
sodium-hypochlorite in endodontic therapy. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod 1983;55:307-12. 
49. John Harrison RH. The effect of dilution and organic matter on the antibacterial 
property of 5.25% sodium hypochlorite. J Endod 1981;7:128-32. 
50. Mohammadi Z. Sodium hypochlorite in endodontics: an update review. Int Dent J 
2008;58:329-41. 
51. Retamozo B, Shabahang S, Johnson N, Aprecio RM, Torabinejad M. Minimum 
contact time and concentration of sodium hypochlorite required to eliminate 
Enterococcus faecalis. J Endod 2010;36:520-3. 
52. Hand RE, Smith ML, Harrison JW. Analysis of the effect of dilution on the 
necrotic tissue dissolution property of sodium hypochlorite. J Endod 1978;4:60-4. 
85 
 
53. Ballal N, Mala, K., Bhat, K. Effect of maleic acid and ethylenediaminetetraacetic 
acid on the dissolution of human pulp tissue – an in vitro study. Int Endod J 
2011;44:353–6. 
54. Calt S, Serper, A. Time-dependent effects of EDTA on dentin structures. J Endod 
2002;28:17-9. 
55. Baumgartner C, Mader, C. A scanning electron microscopic evaluation of four 
root canal irrigation regimens. J Endod 1987;13:147-57. 
56. Ohara P, Torabinejad, M. Kettering, J. Antibacterial effects of various endodontic 
irrigants on selected anaerobic bacteria. Endod Dent Traumatol 1993;9:95-100. 
57. Singla MG, Garg A, Gupta S. MTAD in endodontics: an update review. Oral Surg 
Oral Med Oral Pathol Oral Radiol Endod 2011;112:e70-6. 
58. Malkhassian G, Manzur AJ, Legner M, et al. Antibacterial efficacy of MTAD 
final rinse and two percent chlorhexidine gel medication in teeth with apical 
periodontitis: a randomized double-blinded clinical trial. J Endod 2009;35:1483-
90. 
59. Dornelles-Morgental R, Guerreiro-Tanomaru JM, de Faria-Junior NB, Hungaro-
Duarte MA, Kuga MC, Tanomaru-Filho M. Antibacterial efficacy of endodontic 
irrigating solutions and their combinations in root canals contaminated with 
Enterococcus faecalis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
2011;112:396-400. 
60. Oliveira DP, Barbizam JV, Trope M, Teixeira FB. In vitro antibacterial efficacy 
of endodontic irrigants against Enterococcus faecalis. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod 2007;103:702-6. 
61. Vera J, Siqueira JF, Jr., Ricucci D, et al. One- versus two-visit endodontic 
treatment of teeth with apical periodontitis: a histobacteriologic study. J Endod 
2012;38:1040-52. 
62. Basrani B, Manek S., Sodhi, R., Fillery, E., Manzur, A. Interaction between 
sodium hypochlorite and chlorhexidine gluconate. J Endod 2007;33:966-9. 
63. Nowicki J, Sem, D. An in vitro spectroscopic analysis to determine the chemical 
composition of the precipitate formed by mixing sodium hypochlorite and 
chlorhexidine. J Endod 2011;37:983–8. 
64. Thomas J, Sem, D. . An in vitro spectroscopic analysis to determine whether 
parachloroaniline is produced from mixing sodium hypochlorite and 
chlorhexidine. J Endod 2010;2:315–7. 
86 
 
65. Krishnamurthy S, Sudhakaran S. Evaluation and prevention of the precipitate 
formed on interaction between sodium hypochlorite and chlorhexidine. J Endod 
2010;36:1154-7. 
66. Mortenson D, Sadilek M, Flake NM, et al. The effect of using an alternative 
irrigant between sodium hypochlorite and chlorhexidine to prevent the formation 
of para-chloroaniline within the root canal system. Int Endod J 2012;45:878-82. 
67. Schilder H. Filling root canals in three dimensions. Dent Clin North Am 
1967:723-44. 
68. Schilder H. Filling root canals in three dimensions. J Endod 2006;32:281-90. 
69. Grossman LI. Root canal therapy. Philadelphia: Mosby; 1940. 
70. Cohen S, Hargreaves, K, eds.. Pathways of the pulp. 9th ed. St. Louis: Mosby 
Inc.; 2006. 
71. Sargenti A. Debate on N2: is N2 an acceptable method of treatment? Trans Int 
Conf Endod 1973;5:176-95. 
72. Newton CW, Patterson SS, Kafrawy AH. Studies of Sargenti's technique of 
endodontic treatment: six-month and one-year responses. J Endod 1980;6:509-17. 
73. Kim YK, Grandini S, Ames JM, et al. Critical review on methacrylate resin-based 
root canal sealers. J Endod 2010;36:383-99. 
74. Tay FR, Pashley DH, Williams MC, et al. Susceptibility of a polycaprolactone-
based root canal filling material to degradation.(Pt 1 ). Alkaline hydrolysis. J 
Endod 2005;31:593-8. 
75. Tay FR, Pashley DH, Yiu CK, et al. Susceptibility of a polycaprolactone-based 
root canal filling material to degradation. (Pt 2). Gravimetric evaluation of 
enzymatic hydrolysis. J Endod 2005;31:737-41. 
76. Hiraishi N, Yau JY, Loushine RJ, et al. Susceptibility of a polycaprolactone-based 
root canal-filling material to degradation. (Pt 3). Turbidimetric evaluation of 
enzymatic hydrolysis. J Endod 2007;33:952-6. 
77. Baker R. Discussion of clinical findings of the re-treatment of Resilon cases. 
Personal communication; Indianapolis, IN; Feb 25, 2013. 
78. Friedman CM, Sandrik JL, Heuer MA, Rapp GW. Composition and mechanical 
properties of gutta-percha endodontic points. J Dent Res 1975;54:921-5. 
79. Schilder H, Goodman A, Aldrich W. The thermomechanical properties of gutta-
percha. (Pt 3). Determination of phase transition temperatures for gutta-percha. 
Oral Surg Oral Med Oral Pathol 1974;38:109-14. 
87 
 
80. Senia ES, Marraro RV, Mitchell JL, Lewis AG, Thomas L. Rapid sterilization of 
gutta-percha cones with 5.25% sodium hypochlorite. J Endod 1975;1:136-40. 
81. Hamann C, Rodgers PA, Alenius H, Halsey JF, Sullivan K. Cross-reactivity 
between gutta-percha and natural rubber latex: assumptions vs. reality. J Am Dent 
Assoc 2002;133:1357-67. 
82. Kang PB, Vogt K, Gruninger SE, Marshall M, Siew C, Meyer DM. The immuno 
cross-reactivity of gutta percha points. Dent Mater 2007;23:380-4. 
83. Peng L, Ye L, Tan H, Zhou X. Outcome of root canal obturation by warm gutta-
percha versus cold lateral condensation: a meta-analysis. J Endod 2007;33:106-9. 
84. Reader CM, Himel VT, Germain LP, Hoen MM. Effect of three obturation 
techniques on the filling of lateral canals and the main canal. J Endod 
1993;19:404-8. 
85. Schaeffer MA, White RR, Walton RE. Determining the optimal obturation length: 
a meta-analysis of literature. J Endod 2005;31:271-4. 
86. Anders Bystrom RC, Goran Sundqvist. The antibacterial effect of camphorated 
paramonochlorophenol, camphorated phenol and calcium hydroxide in the 
treatment of infected root canals. Endod Dent Traumatol 1985;1:170-5. 
87. Fuss Z, Szajkis S, Tagger M. Tubular permeability to calcium hydroxide and to 
bleaching agents. J Endod 1989;15:362-4. 
88. Shuping GB, Orstavik D, Sigurdsson A, Trope M. Reduction of intracanal 
bacteria using nickel-titanium rotary instrumentation and various medications. J 
Endod 2000;26:751-5. 
89. Andreasen JO, Farik B, Munksgaard EC. Long-term calcium hydroxide as a root 
canal dressing may increase risk of root fracture. Dent Traumatol 2002;18:134-7. 
90. Tanomaru JM, Leonardo MR, Tanomaru Filho M, Bonetti Filho I, Silva LA. 
Effect of different irrigation solutions and calcium hydroxide on bacterial LPS. Int 
Endod J 2003;36:733-9. 
91. Safavi KE, Nichols FC. Effect of calcium hydroxide on bacterial 
lipopolysaccharide. J Endod 1993;19:76-8. 
92. Akgun OM, Altun C, Guven G. Use of triple antibiotic paste as a disinfectant for 
a traumatized immature tooth with a periapical lesion: a case report. Oral Surg 
Oral Med Oral Path Oral Rad Endod 2009;108:E62-E5. 
93. Banchs F, Trope M. Revascularization of immature permanent teeth with apical 
periodontitis: new treatment protocol? J Endod 2004;30:196-200. 
88 
 
94. Yassen G. VM, Chu T., Platt J. The effect of medicaments used in endodontic 
regeneration on root fracture and microhardness of radicular dentine. Int Endod J 
2013;46:1-8. 
95. Kim JH, Kim Y, Shin SJ, Park JW, Jung IY. Tooth discoloration of immature 
permanent incisor associated with triple antibiotic therapy: a case report. J Endod 
2010;36:1086-91. 
96. Iwaya SI, Ikawa M, Kubota M. Revascularization of an immature permanent 
tooth with apical periodontitis and sinus tract. Dent Traumatol 2001;17:185-7. 
97. Oliveira LD, Carvalho CA, Carvalho AS, Alves Jde S, Valera MC, Jorge AO. 
Efficacy of endodontic treatment for endotoxin reduction in primarily infected 
root canals and evaluation of cytotoxic effects. J Endod 2012;38:1053-7. 
98. Siqueira JF, Jr., Rocas IN. Optimising single-visit disinfection with 
supplementary approaches: a quest for predictability. Aust Endod J 2011;37:92-8. 
99. Miorin PL, Levy Junior NC, Custodio AR, Bretz WA, Marcucci MC. 
Antibacterial activity of honey and propolis from Apis mellifera and Tetragonisca 
angustula against Staphylococcus aureus. J Appl Microbiol 2003;95:913-20. 
100. Keskin N, Hazir S, Baser KH, Kurkcuoglu M. Antibacterial activity and chemical 
composition of Turkish propolis. Z Naturforsch C 2001;56:1112-5. 
101. Kosalec I, Pepeljnjak S, Bakmaz M, Vladimir-Knezevic S. Flavonoid analysis and 
antimicrobial activity of commercially available propolis products. Acta Pharm 
2005;55:423-30. 
102. Steinberg D, Kaine G, Gedalia I. Antibacterial effect of propolis and honey on 
oral bacteria. Am J Dent 1996;9:236-9. 
103. Kouidhi B, Zmantar T, Bakhrouf A. Anti-cariogenic and anti-biofilms activity of 
Tunisian propolis extract and its potential protective effect against cancer cells 
proliferation. Anaerobe 2010;16:566-71. 
104. Mattigatti S, Ratnakar P, Moturi S, Varma S, Rairam S. Antimicrobial effect of 
conventional root canal medicaments vs propolis against Enterococcus faecalis, 
Staphylococcus aureus and Candida albicans. J Contemp Dent Pract 
2012;13:305-9. 
105. McLennan SV, Bonner J, Milne S, et al. The anti-inflammatory agent propolis 
improves wound healing in a rodent model of experimental diabetes. Wound 
Repair Regen 2008;16:706-13. 
106. Harris A, Holliday, L., Pileggi, R. Propolis blocks osteoclastogenesis downstream 
of the cyclooxygenase. [Abstract] Int Asoc Dent Res 2009; Miami, FL. 
89 
 
107. Bulman Z, Le P, Hudson AO, Savka MA. A novel property of propolis (bee glue): 
Anti-pathogenic activity by inhibition of N-acyl-homoserine lactone mediated 
signaling in bacteria. J Ethnopharmacol 2011;138:788-97. 
108. Kayaoglu G, Omurlu H, Akca G, et al. Antibacterial activity of propolis versus 
conventional endodontic disinfectants against Enterococcus faecalis in infected 
dentinal tubules. J Endod 2011;37:376-81. 
109. Uzel A, Sorkun K, Oncag O, Cogulu D, Gencay O, Salih B. Chemical 
compositions and antimicrobial activities of four different Anatolian propolis 
samples. Microbiol Res 2005;160:189-95. 
110. Onlen Y, Duran N, Atik E, et al. Antibacterial activity of propolis against MRSA 
and synergism with topical mupirocin. J Altern Complement Med 2007;13:713-8. 
111. Ferreira FB, Torres SA, Rosa OP, et al. Antimicrobial effect of propolis and other 
substances against selected endodontic pathogens. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod 2007;104:709-16. 
112. Dziedzic A, Kubina R, Wojtyczka RD, Kabala-Dzik A, Tanasiewicz M, 
Morawiec T. The antibacterial effect of ethanol extract of polish propolis on 
mutans streptococci and lactobacilli isolated from saliva. Evid Based Complement 
Alternat Med 2013;2013:681891. 
113. Kandaswamy D, Venkateshbabu N, Gogulnath D, Kindo AJ. Dentinal tubule 
disinfection with 2% chlorhexidine gel, propolis, morinda citrifolia juice, 2% 
povidone iodine, and calcium hydroxide. Int Endod J 2010;43:419-23. 
114. Neiva K, Botero T, Holliday L, Wallet S, Pileggi R. Propolis effects inflammatory 
cytokine expression in pulp cells and osteoclasts. [Abstract] Int Assoc Dent Res 
2011; San Diego, CA. 
115. Parolia A, Kundabala M, Rao NN, et al. A comparative histological analysis of 
human pulp following direct pulp capping with Propolis, mineral trioxide 
aggregate and Dycal. Aust Dent J 2010;55:59-64. 
116. Al-Shaher A, Wallace J, Agarwal S, Bretz W, Baugh D. Effect of propolis on 
human fibroblasts from the pulp and periodontal ligament. J Endod 2004;30:359-
61. 
117. Sabir A, Tabbu CR, Agustiono P, Sosroseno W. Histological analysis of rat dental 
pulp tissue capped with propolis. J Oral Sci 2005;47:135-8. 
118. Ilewicz L, Szczurek Z, Szenowski H, Luciak M, Ciesielski A, Scheller S. 
[Healing of injured dental pulp covered by an ethanol extract of propolis (EEP) in 
light of morphological studies]. Czas Stomatol 1986;39:632-42. 
90 
 
119. Gjertsen AW, Stothz KA, Neiva KG, Pileggi R. Effect of propolis on proliferation 
and apoptosis of periodontal ligament fibroblasts. Oral Surg Oral Med Oral Pathol 
Oral Radiol Endod 2011;112:843-8. 
120. Pileggi R, Antony K, Johnson K, Zuo J, Shannon Holliday L. Propolis inhibits 
osteoclast maturation. Dent Traumatol 2009;25:584-8. 
121. Victorino FR, Bramante CM, Zapata RO, et al. Removal efficiency of propolis 
paste dressing from the root canal. J Appl Oral Sci 2010;18:621-4. 
122. Parolia A kM. Non-surgical re-treatment of failed surgical endodontic therapy 
using propolis as an intra-canal medicament: a case report. Res J Med Sci 
2010;4:292-7. 
123. Signat B, Roques C, Poulet P, Duffaut D. Fusobacterium nucleatum in 
periodontal health and disease. Curr Issues Mol Biol 2011;13:25-36. 
124. Puntervoll P, Kleivdal H, Dahl KO, Bitter W, Tommassen J, Jensen HB. The 
Fusobacterium nucleatum porin FomA possesses the general topology of the non-
specific porins. Microbiol 2000;146 ( Pt 6):1437-45. 
125. Liu PF, Shi W, Zhu W, et al. Vaccination targeting surface FomA of 
Fusobacterium nucleatum against bacterial co-aggregation: implication for 
treatment of periodontal infection and halitosis. Vaccine 2010;28:3496-505. 
126. Kaplan CW, Lux R, Haake SK, Shi W. The Fusobacterium nucleatum outer 
membrane protein RadD is an arginine-inhibitable adhesin required for inter-
species adherence and the structured architecture of multispecies biofilm. Mol 
Microbiol 2009;71:35-47. 
127. Kaplan CW, Ma X, Paranjpe A, et al. Fusobacterium nucleatum outer membrane 
proteins Fap2 and RadD induce cell death in human lymphocytes. Infect Immun 
2010;78:4773-8. 
128. Rocas IN, Siqueira JF, Jr. Root canal microbiota of teeth with chronic apical 
periodontitis. J Clin Microbiol 2008;46:3599-606. 
129. Siqueira JF, Jr., Rocas IN. The microbiota of acute apical abscesses. J Dent Res 
2009;88:61-5. 
130. Gomes BP, Pinheiro ET, Gade-Neto CR, et al. Microbiological examination of 
infected dental root canals. Oral Microbiol Immunol 2004;19:71-6. 
131. Sassone LM, Fidel RA, Faveri M, Figueiredo L, Fidel SR, Feres M. A 
microbiological profile of unexposed and exposed pulp space of primary 
endodontic infections by checkerboard DNA-DNA hybridization. J Endod 
2012;38:889-93. 
91 
 
132. Siqueira JF, Jr., Rocas IN, Alves FR, Santos KR. Selected endodontic pathogens 
in the apical third of infected root canals: a molecular investigation. J Endod 
2004;30:638-43. 
133. Baumgartner JC, Siqueira JF, Jr., Xia T, Rocas IN. Geographical differences in 
bacteria detected in endodontic infections using polymerase chain reaction. J 
Endod 2004;30:141-4. 
134. Siqueira JF, Jr. Treatment of endodontic infections. Quintessence; 2011. 
135. Estrela AB, Heck MG, Abraham WR. Novel approaches to control biofilm 
infections. Curr Med Chem 2009;16:1512-30. 
136. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural 
environment to infectious diseases. Nat Rev Microbiol 2004;2:95-108. 
137. Macedo AJ, Abraham WR. Can infectious biofilm be controlled by blocking 
bacterial communication? Med Chem 2009;5:517-28. 
138. Huang R, Li M, Gregory RL. Effect of nicotine on growth and metabolism of 
Streptococcus mutans. Eur J Oral Sci 2012;120:319-25. 
139. Parolia A kM. Non-surgical re-treatment of failed surgical endodontic therapy 
using propolis as an intra-canal medicament: a case report. Res J Med Sci 
2010;4:292-7. 
140. Seidel V, Peyfoon E, Watson DG, Fearnley J. Comparative study of the 
antibacterial activity of propolis from different geographical and climatic zones. 
Phytother Res 2008;22:1256-63. 
141. Velazquez C, Navarro M, Acosta A, et al. Antibacterial and free-radical 
scavenging activities of Sonoran propolis. J Appl Microbiol 2007;103:1747-56. 
142. Gebara ECE LL, Mayer MPA. Propolis antimicrobial activity against 
periodontopathic bacteria. Brazil J Microbiol 2002;33:365-9. 
143. Koru O, Toksoy F, Acikel CH, et al. In vitro antimicrobial activity of propolis 
samples from different geographical origins against certain oral pathogens. 
Anaerobe 2007;13:140-5. 
144. Saito Y, Fujii R, Nakagawa KI, Kuramitsu HK, Okuda K, Ishihara K. Stimulation 
of Fusobacterium nucleatum biofilm formation by Porphyromonas gingivalis. 
Oral Microbiol Immunol 2008;23:1-6. 
145. Ozok AR, Wu MK, Luppens SB, Wesselink PR. Comparison of growth and 
susceptibility to sodium hypochlorite of mono- and dual-species biofilms of 
Fusobacterium nucleatum and Peptostreptococcus (micromonas) micros. J Endod 
2007;33:819-22. 
92 
 
146. Bachrach G, Ianculovici C, Naor R, Weiss EI. Fluorescence based measurements 
of Fusobacterium nucleatum coaggregation and of fusobacterial attachment to 
mammalian cells. FEMS Microbiol Lett 2005;248:235-40. 
147. Stepanovic S, Vukovic D, Hola V, et al. Quantification of biofilm in microtiter 
plates: overview of testing conditions and practical recommendations for 
assessment of biofilm production by staphylococci. APMIS 2007;115:891-9. 
148. O'Toole G KH, Kolter R. Biofilm formation as microbial development. Annu Rev 
Microbiol 2000;54:49-79. 
149. Peeters E, Nelis HJ, Coenye T. Resistance of planktonic and biofilm-grown 
Burkholderia cepacia complex isolates to the transition metal gallium. J 
Antimicrob Chemother 2008;61:1062-5. 
150. Pierce CG, Thomas DP, Lopez-Ribot JL. Effect of tunicamycin on Candida 
albicans biofilm formation and maintenance. J Antimicrob Chemother 
2009;63:473-9. 
151. Yamane K, Nambu T, Yamanaka T, et al. Pathogenicity of exopolysaccharide-
producing Actinomyces oris isolated from an apical abscess lesion. Int Endod J 
2013;46:145-54. 
152. Douwes RA, van der Kolk JH. [Dimethylsulfoxide (DMSO) in horses: a literature 
review]. Tijdschr Diergeneeskd 1998;123:74-80. 
153. Cuenca-Estrella M, Moore CB, Barchiesi F, et al. Multicenter evaluation of the 
reproducibility of the proposed antifungal susceptibility testing method for 
fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the 
European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). 
Clin Microbiol Infect 2003;9:467-74. 
154. Joly S, Maze C, McCray PB, Jr., Guthmiller JM. Human beta-defensins 2 and 3 
demonstrate strain-selective activity against oral microorganisms. J Clin 
Microbiol 2004;42:1024-9. 
155. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. 
Annu Rev Microbiol 2000;54:49-79. 
156. Pitts B, Hamilton MA, Zelver N, Stewart PS. A microtiter-plate screening method 
for biofilm disinfection and removal. J Microbiol Methods 2003;54:269-76. 
157. Basch H, Gadebusch HH. In vitro antimicrobial activity of dimethylsulfoxide. 
Appl Microbiol 1968;16:1953-4. 
 
 
93 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
 
 
 
 
 
 
 
 
 
 
 
94 
 
 
 
 
EFFICACY OF PROPOLIS AGAINST FUSOBACTERIUM 
 NUCLEATUM BIOFILM 
 
 
 
 
by 
 
Anthony Leonard Griglione 
Indiana University School of Dentistry 
Indianapolis, Indiana  
 
 The primary goal of root canal treatment is to eliminate microbes from the root 
canal system, which is the cause of pulpal and periapical infections. Research shows that 
after a single visit of chemomechanical debridement microbes continue to remain within 
the canal system. An interappointment medication step has been advocated to maximize 
potential elimination of microbes within the root canal system. Previous studies have 
shown propolis to be antibacterial against common endodontic microbes. Studies have 
shown trends in different microbes being present in primary verus secondary endodontic 
infections.  The majority of literature has focused on the efficacy of propolis against 
Enterococcus faecalis, a microbe commonly implicated in secondary endodontic 
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infections.  The aim of this study was to demonstrate the efficacy of propolis against 
Fusobacterium nucleatum, a microbe commonly found in primary endodontic infections.   
This study aims to demonstrate the efficacy of propolis against a bacterium of 
primary endodontic infections (F. nucleatum) as well as against microbial biofilm to 
further support its potential use as a novel intracanal medicament. Dilutions of propolis 
were added to cultures of F. nucleatum in microtiter plates in a range from 390 μg/ml to 
50,000 μg/ml. The minimum inhibitory concentration (MIC), minimum bactericidal 
concentration (MBC), and the minimum biofilm inhibitory concentration (MBIC) were 
determined.  The MIC was determined of the total solution (biofilm+planktonic), 
planktonic, and biofilm (MBIC) after a 48-hour incubation period. The MBIC was 
determined by fixing biofilm to the wells and using crystal violet staining with 
spectrophotometry.  The MBC was examined by plating solution from each concentration 
test well and reading the plates after 48 hours of incubation.   
The results show that the MIC of the total (biofilm+planktonic) appears to occur 
at a concentration of 6250 μg/ml. The MBIC appears to occur at the concentration of 
1562.5 μg/ml. The planktonic results exhibit no significant difference in test and control 
wells. There was no MBC at any of the test concentrations. The propolis appears to 
inhibit bacterial growth and biofilm formation but does not appear to be bactericidal at 
any of the tested concentrations.   
The results of this study indicate that propolis has an MIC and MBIC when tested 
in vitro against F. nucleatum, although it does not show an MBC. There appears to be 
potentially significant interaction of propolis with biofilm as displayed by the lower 
concentration needed to exibit inhibitory effects on biofilm formation. This information 
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may contribute to the ability to develop a proper concentration of propolis to use in vivo 
when treating endodontic infections. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CURRICULUM VITAE 
 
 
 
 
 
 
 
 
 
 
 
 
Anthony Leonard Griglione 
 
August 1998 to June 2002 Champaign Central  
High School 
Champaign, IL 
Diploma, June 2002 
 
August 2002 to May 2006 University of Illinois 
 Urbana, IL 
 BS, Integrative Biology 
 
August 2006 to June 2010 Southern Illinois 
University 
 School of Dental 
Medicine 
 Alton, IL 
 DMD 
 
June 2010 to May 2011 Private Practice 
 Saint Louis, MO 
 
July 2011 to June 2013 Indiana University 
 School of Dentistry 
 Graduate Endodontics 
 Indianapolis, IN  
 
Professional Organizations 
 
2009 to present American Association 
of Endodonists 
 
2006 to present American Dental 
Association 
 
 
 
 
 
 
